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View Article OnlineThis update is a little shorter than in recent years, reflecting the
fewer original papers published. However, the trend for a large
number of review articles has continued and these cover a wide
range of important topics. In the 2012 update, a noticeable
increase in work involving very small samples was evident. These
observations continue through into the current review. This
was particularly seen with sample introduction systems used for
ICP-MS. A microflow device for aerosol generation, based on
thermal inkjet technology, provided for analysis of highly
dissolved solids at a flow rate of 1 mL min1 while other high
performance arrangements were described which operated at
slightly larger delivery rates. As in previous years, major topics
include investigations of the metabolism of As and Se. We have
also previously reported on the techniques to measure Pt–DNA
adducts, developed in the last few years. It is encouraging to see
that these are now being applied to studies of platinum anti-
cancer treatments in cell cultures and in patients. There are some
interesting new methodologies. Quantum dots appeared for the
first time in this review with an indirect assay for measuring very
low concentrations of protein in urine. A protein conjugate
formed with CdTe quantum dots was isolated and the Cd
measured by ICP-MS. XRF has poor sensitivity for low atomic
number elements but in another indirect assay, Li in mineral water
was determined by forming a potassium lithium periodatoferrate
complex and measuring the Fe. Magnetic particles are used in
some immunoassays to effect separation of reagents and a similar
approach was developed using Fe3O4 magnetite nanoparticles
modified with 1-(p-acetyl)phenyl)-3-(o-ethoxyphenyl)triazene to
extract and preconcentrate Hg from water and fish samples.
Concern over the amount of As in fish and rice and the potential
for this element to appear in other food products is evident from
studies involving fish oils and organic brown rice syrup. Anyone
tempted to eat alligator meat can be reassured that
concentrations of Cd, and Pb are very low. We are pleased to have
a new contributor to this review; Sarah Hill has considerable
experience with ICP-MS techniques including the use of this
technique for imaging.1 Reviews
This latest update adds to that from last year1 and complements
other reviews of instrumental techniques in the series of Atomic
Spectrometry Updates from the last year.2–6 Two reviews, with
different authors but featuring the same department in Santa
Maria, Brazil, discussed how analysis of biological samples
using ICP-MS has developed during the last 10–15 years. One
concentrated primarily on sample preparation strategies, such
as extraction and solubilisation, derivatisation, pre-concentra-
tion, appropriate for analyte separation and speciation.7 The
second was directed at techniques applied to speciation of
vapour forming elements, LC-, GC-, CE-ICP-MS.8
Other reviews dealing with sample preparation focussed on
micro-extraction procedures, reinforcing the observations made
in our recent ASUs about the growing interest in this approach
to the analysis of foods9 and other biological specimens.10,11J. Anal. At. Spectrom.Although discussed in more detail in a separate ASU,6 speci-
ation is particularly important for biological samples. Relevant
reviews from this last year include a presentation from the 4th
IUPAC Symposium on Trace Elements in Food12 in which
Lobinski and his colleagues related analytical developments to
food regulations and quality control of production. Opportuni-
ties for expansion of this type of work provided by ES-HR-ICP-MS
were also mentioned. The more specic topics of CRMs for Hg
speciation,13 Hg speciation in seafood14 and I in environmental
and biological materials15 were also reviewed. Ibanez-Palomino
et al.13 listed the characteristics of an ideal biological CRM forHg
in terms of matrix, species present and their concentrations and
compared these against the CRMs used in recent research
papers. Clemens et al.14 in a very specialised review looked at
species-specic and species-unspecic ID-analysis as used to
demonstrate and correct for inter-species transformations of Hg
during sample preparation. Determination and speciation of I in
clinical samples has not previously received much attention but
Mereda-Pineiro et al.15 have now comprehensively reviewed
workwith this biologically important element discussing sample
pre-treatment, techniques for measurement, approaches to
speciation and the role of I in the environment and in humans.
Exposure to undue levels of Cd is now uncommon in many
countries but still has considerable economic importance in
some parts of the world. Thus, Wu et al.16 described new work
since 2006 (224 references) in terms of analysis, speciation,
imagingwithin cells and toxicity of Cd-containing quantumdots.
From the work discussed in Section 5.2, it is evident that the
interest in showing the distribution of elements within tissues
and cells is increasing. An extensive review of tissue analysis by
imaging MS was prepared by Oppenheimer and Drexler.172 Metrology, interlaboratory studies,
reference ranges
The rationale for determination of measurement uncertainty,
together with validation of an analytical method, so as to give
high quality data which may be assessed with respect to statu-
tory limits, reference limits and data from other studies, was
presented by Bocca et al.18 In applying their principles to the
validation of analytical procedures to measure 20 elements in
human blood, these workers reported linearity, LODs, bias on
CRMs, repeatability, reproducibility and expanded uncertainty.
In keeping with this philosophy, Jitaru et al.19 measured six
elements in tomato paste by HR-ICP-MS, presenting themethod
validation data including the measurement uncertainty.
In previous ASUs, we have referred to work for in vivo
measurement of Pb in bone using XRF and have highlighted
various analytical and calibration problems associated with
what is still a developing technique. Bellis et al.20 from the New
York State Department of Health initiated an interlaboratory
comparison study using tibia from their Pb-dosed goats. Nine
samples were distributed with concentrations of 1.8–35.8 mg g1
dw (measured by ICP-MS). Themean reported values were in the
range 4–55.3 mg g1 bone mineral. Results from eight of the
participants showed no signicant bias while the remaining
















































View Article Onlineneed for further work before in vivo XRF can be regarded as a
reliable technique for bone Pb measurement.
The national metrological institutes of Japan and the USA
(NMIJ and NIST) independently report development and certi-
cation of CRMs for trace elements in dried tea leaves and a
green tea extract, respectively.21,22 The NIST also presented work
on the identication and quantication of selenoproteins
(selenoprotein P, glutathione peroxidase 3 and selenoalbumin)
in a candidate human plasma SRM.23
Ethical considerations associated with collecting blood
samples from children mean that there are limited reliable
reference ranges for many parameters, including trace elements.
This was exemplied by Zeager et al.24 who obtained the ranges
reported from 10 different laboratories for Al in plasma, serum
or urine. These varied considerably and the authors concluded
that further work in association with the CDC Biomonitoring
Project should be considered. However, Lin et al.25 were given
approval to take blood samples from 2115 healthy children in
the USA, aged 0.5–18 years and measured concentrations of Cu
and Zn in the serum. There were no differences associated with
gender or fasting status. The reference interval for Zn was 64 to
124 mg dL1 while for Cu the age related ranges were: 75–153 for
those less than 10.3 years, 64–153 for those aged 10.3 to 12.5
years and 57–129 for those older than 12.5 years (concentrations
in mg dL1). These Cu values are inconsistent with those from
other workers who foundmuch lower concentrations in infants,
with adult levels (76–160 mg dL1) being attained by about one
year of age and no change thereaer. The decrease beyond 10
years of age has not previously been reported. For an Italian
biomonitoring programme, the concentrations of 20 elements
were measured in blood from 252 subjects aged 13–15 years,
using HR-ICP-MS.26 As part of a project to assess release of Ti
from bone xation implants, a method was established to
determine concentrations of the metal in serum using HR-ICP-
MS and samples from 40 control subjects were analysed.27 The
mean value was 0.26 mg L1. Further work established that more
than 99.8% of the Ti was bound to transferrin. Within the
context of a cognitive function and ageing study, House et al.28
measured Al, Cu and Fe in four regions of brains from 60 aged
subjects. The sample preparation and analysis included exten-
sive precautions to reduce contamination which was monitored
by regular inclusion of blank samples. The dry weight concen-
trations, in mg g1, were: not detected (ND) to 33, ND to 384 and
112–8305 for Al, Cu and Fe, respectively. Median values were
1.02, 17.41 and 286.16 mg g1, respectively.3 Sample collection and preparation
3.1 Collection and storage
Developments in recent years that have increased the sensitivity
for analyses mean that potential contamination during sample
collection, storage and analysis has become even more impor-
tant. Hodnett et al.29 collected blood from 10 volunteers using
stainless steel needles, “buttery” winged infusion needles and
plastic cannulae. The samples were then analysed for Co, Cr,
Mn and Ni by ICP-MS. While there was no signicant differ-
ences in concentrations associated with the different devicesThis journal is ª The Royal Society of Chemistry 2013some unexpectedly increased results were obtained. It was
recommended that stainless steel needles may be used but that
a repeat specimen is collected using a plastic cannula if an
aberrant result is obtained. In addition to the collection
procedure, the specimen tube may also be responsible for
producing erroneous results. Contamination of the sample is
well recognised but Malavolta et al.30 demonstrated that EDTA
used as the anticoagulant will give erroneous results in inves-
tigations of elemental speciation in plasma. By contrast,
lithium-heparin anticoagulant was acceptable.
In someprevious ASUs,wementionedwork inwhich real-time
measurements were made in blood that was pumped from a vein
through to the analytical system. This approach has been further
developed as seen in the report by Su and colleagues.31 In their
recent work, saline-perfused rat brain extracellular uid was
taken to a microdialysis unit with a polycarbonate membrane
where it was mixed with maleic acid, through 80 cm 0.018 cm
i.d. PTFE tubing which acted as a solid phase extraction to
remove the salt matrix and enrich the analyte concentrations for
determination by ICP-MS. The analytes were detached from the
PFTE tubingwith 0.5%HNO3. Aer establishing the perfusion in
anaesthetised rats, concentrations of Cu, Mn, Ni and Zn were
monitored following intra-peritoneal administration of a dose of
MnSO4. The concentration of Mn increased in the brain's
extracellular uid but there were no changes involving the
other ions.3.2 Digestion, extraction and preconcentration
In an elaborate investigation to optimise conditions for micro-
wave-assisted digestion of sh samples, Low et al.32 varied
microwave power, time, heating ramp rate, digestion tempera-
ture and addition of H2O2 or HCl. Of these, the radiation time,
ramp and temperature were the most important but the best
settings were element specic. It was reported that the most
useful compromised conditions were to ramp to 185 C in 10.5
min, hold for 14.5 min, with 1600 W microwave power. The
reagents used were 2.5 mL HNO3, 0.5 mL HCl and 7 mL H2O.
The recommended conditions for microwave digestion of our
were reported by Ren et al.33 Polgari et al.34 compared ‘normal-
volume’microwave digestion, digestion usingmicro vessels and
vapour-phase digestion. The normal-volume approach afforded
better destruction of organic matrix and dilution of inorganic
residue but higher LODs compared with the other procedures
due to the greater dilution factors. For this reason, it is
preferred for quantication by XRF because of reduced back-
ground and self-absorption of the uorescent radiation.
Ultrasound-assisted extraction continues to be used with
tissues and food samples. In a novel arrangement, Zhang et al.35
achieved 40% increase in the extraction of organic Hg species
from seafood samples when a combination of ultrasonic bath
and ultrasonic probe was used. Inorganic and total Hg were
completely extracted within 60 s as shown by analysis of CRMs.
Reviews of work involving microextraction procedures were
cited in Section 1. New work reported in the last year included
the measurement of Hg in human saliva by AFS. This involved
















































View Article Onlineby extraction into ne droplets of 1-undecanol which were
cooled to solidify into a microdrop.36 An enrichment factor of
182 was reported, giving an LOD of 2.5 ng L1. Variations
around this general approach were used to determine the
concentrations of As in blood and urine by HG-AAS37 with LODs
of 5 ng L1 and 0.02–10 mg L1, respectively, and Se species in
garlic by ETAAS38 for which the LOD was 15 ng L1.
Reports of new procedures for more conventional pre-
concentration were also seen during the last year. Rofouei et al.39
added Fe3O4 magnetite nanoparticles modied with 1-( p-ace-
tylphenyl)-3-(o-ethoxyphenyl)triazene to samples to effect
adsorption of Hg2+. The particles were recovered by application
of a magnetic eld and the Hg2+ eluted for measurement by
ICP-AES. The technique was used for analysis of water and sh
samples providing analyte enhancement of up to 500-fold. A
glass microcolumn packed with thioureidopropyl functional-
ized silica gel was used by Kovachev et al.40 to enhance the
concentration of Pd from serum and urine 90-fold. Methodo-
logical parameters, ow rate etc. were optimised and elution
from the column was facilitated by microwave irradiation.
Digests of food samples, with the pH adjusted to more than 7,
were applied to a chelating column containing InertSep ME-1
and the Cd eluted with 0.2 MHNO3.41 This procedure achieved a
modest increase in concentration but more usefully it removed
Mo, Sn and Zr which caused a spectral interference within the
measurement of Cd by ID-ICP-MS.4 Progress with analytical techniques
4.1 Progress with analytical techniques: mass spectrometry
4.1.1 Inductively coupled plasma-mass spectrometry.
Oen, biological sample analysis is restricted by quantity or
volume. Recent studies used microow nebulisers to overcome
this. A new aerosol generation system, based on thermal inkjet
technology, termed ‘drop-on-demand’ (DOD) was reported by
von Niessen et al.42 The technique enabled the use of ultra-low
ow rates (1 mL min1) for samples with high dissolved solids,
such as urine and serum, to be analysed without causing clog-
ging/blockages which is commonly observed with other micro-
ow nebuliser systems. Calibration was achieved using a dosing
frequency-based technique and could be applied for external
calibration or standard addition in the case of complex
matrices. Lariviere et al.43 described the use of a high matrix
interface system for the measurement of Be in autopsy tissues.
Aer optimisation, the instrumental LODwas 0.6 ng L1 despite
the high level of salt present in digests from samples such as
bone or hair. The theme of small volumes was echoed by
Takasaki et al.44 who reported the development of a micro-
volume sample introduction system for ICP-MS. The system
comprised of a 20 mL injection loop with a high-performance
concentric nebuliser and heated cyclonic spray chamber, giving
a ow rate of 10 mL min1 and good signal stability. Validation
using NIST SRM 1577b gave results in good agreement with
certied values and, with other analytes, demonstrated the
applicability to clinical micro-volume samples. Bentlin et al.45
also described the use of FI for the analysis of lanthanide
elements in red wine aer ultrasonic digestion for originJ. Anal. At. Spectrom.discriminatory purposes. Micro-volumes of sample (50 mL) were
used in combination with a PFA micro-nebuliser and aerosol
desolvation.
The inclusion of on-line sample preparation to small volume
analysis was applied by Su et al.31 for the in vivo analysis of rat
brain extracellular uid. Micro-dialysis was used to extract the
samples whilst SPE was used to preconcentrate and remove salt
from the matrix. Excellent LODs and CRM recoveries were
obtained for the system, offering a valuable insight into in vivo
metal interaction in brain extracellular uid. Direct online
analysis was also demonstrated by Leufroy et al.46 to investigate
the bioavailability of As in seafood samples. The method
showed benets over batch processes due to the constant
removal of the leached species.
The optimisation of collision/reaction cell ICP-MS for the
measurement of As, Co, Cr, Fe, Ni, Se and V in food products
was reported by Kadar and colleagues.47 An experimental design
approach was applied to determine the optimum conditions for
best analytical performance versus interference removal. In
another work, Richardson et al.48 described Mn analysis in
whole blood and plasma without the use collision cell tech-
nology. This was achieved using a new design of skimmer cone
which successfully removed the FeH interference that could not
be achieved with collision cell mode. The methodology was
validated by external quality assurance samples. Balaram et al.49
discussed using 129Xe, naturally present as a contaminant in Ar,
as an internal standard for the analysis of water. It was validated
using NIST SRMs and typically achieved <5% RSD. It offered an
alternative internal standardisation approach to minimise off-
line sample preparation or sample dilution when mixed online.
A review article by Khouzam et al.12 summarised the current
position of analytical techniques and methods required for state of
the art speciation in food products. The application of speciation
analysis in the food industry is growing, particularly with
legislation drivers, e.g., CrIII and CrVI. The review also discussed
the wider availability of ESI-MSn which has enabled signicant
advances in this research eld. Preud'homme et al.50 applied
SEC-ICP-MS with ESI-MSn for the identication of selenium
metabolites from the conversion of selenite into organic
compounds and the enrichment of selenium in yeast.
The combination of dual analysis by ICP-MS and other organic-
based MS continues to provide structural data with elemental
identication for a variety of applications. Easter et al.51 reported
the use of SEC-ICP-MS and LC-MALDI-TOF/TOF for the investi-
gation of selenium interaction with protein markers related to
cerebral vasospasm in stroke patients. Although the work was
preliminary, the proof of concept was demonstrated along with
the need for further research. The elucidation of the metabolic
pathway for a gold-containing drugusingLC-ICP-MS andLC-ESI-
MS was described by Albert el al.52 In a similar approach, Meer-
mann et al.53 reported the use ofHPLC-ICP-MS combinedwith ID
analysis and ESI-MS to determine the metabolites of a bromine-
containing anti-tuberculosis drug. The use of faeces offered an
in vivo measurement approach that avoided the use of 14C
radiolabels in clinical studies.
In what is possibly a unique piece of work, Tang et al.54
















































View Article Onlineprotein. Bio-conjugates were formed between proteins and a
CdTe quantum dots label. The Cd signal measured by ICP-MS
was shown to be directly proportional to the concentration of
protein, providing an extraordinarily sensitive assay. The LOD
for human urine was 0.008 mg mL1.
Calibration strategies for analysis of single hair strands by
LA-ICP-MS were investigated by Kumtabtim et al.55 Using either
powdered hair CRM or human hair doped with known amounts
of analytes, mounted on sticky tape, very similar calibration
curves were produced. The 34S+ ion was used as the internal
standard.
4.1.2 Other mass spectrometry techniques. The use of
other MS techniques for biological analysis has shown devel-
opment. Li et al.56 reported the measurement of U isotope ratios
in human tissue samples of occupationally exposed to U using
TIMS. In a unique but unusual approach, Almstrand and
colleagues57 analysed exhaled particles by TOF-SIMS as an
indirect method of determining the composition of respiratory
tract lining uid. Since this acted as a bio-marker for respiratory
diseases it was possible to successfully discriminate control
individuals and asthma patients using partial least squares
analysis.
A comprehensive study of arsenic biochemistry was described
by de Bettencourt et al.58 using HPLC-ESI-MSn and ESI-FTICR-
MS. The results provided evidence for the metabolic pathways
of As, of which little was previously known.
4.2 Atomic absorption spectrometry
Electrothermal AAS was promoted as a useful technique for
determination of phosphorus in sh diets and faeces.59 The
optimum heating programme, using 1 mg mL1 La as the
chemical modier, was developed and afforded an LOD of
0.15 mg g1 with 100 mg dried sample. This method was said to
be simpler, faster and required a small sample compared with
the usual colorimetric procedures. Concentrations of Al were
measured in wheat our by ETAAS using a high resolution
continuum source analytical system.33
The recent development of high resolution molecular absorp-
tion spectrometry, with ETV to generate the molecular species,
was mentioned in our 2011 ASU.1 Now, the technique has been
applied to the analysis of blood and foods. Aramendia et al.60
measured the concentration of Al in blood as AlF. A modier
with 5% NH4F$HF promoted the formation of AlF and also
improved the destruction of the sample matrix such that
aqueous calibration, rather than standard additions, was
possible. This method, which had an LOD of 1.8 mg L1 was
used to demonstrate a positive correlation between Al concen-
trations in blood and water in a limited number of cases of
death by drowning. Concentrations of F in tea were measured as
the CaF molecule by Welz and his colleagues.61 The LOD was
0.16 mg L1 and the linear range extended to 25 mg L1.
4.3 Atomic emission spectrometry and laser induced
breakdown spectroscopy
There has been very little by way of innovation in the area of
atomic emission during the last year. A procedure involvingThis journal is ª The Royal Society of Chemistry 2013ETV-ICP-AES was used by Mukhtar and Limbeck62 to measure
the concentrations of Ba, Co, Cu, Mn, Ni and Pb in synthetic
gastric juice following extraction from airborne particulates.
The increased sensitivity compared with conventional ICP-
AES was used to show that bioaccessibility of these elements
varied from 32  14% (Ni) to 97  36% (Pb). With a dual
nebulisation system, Benzo et al.63 were able to simulta-
neously measure hydride forming and non-hydride forming
elements by ICP-AES. Results for 16 elements were in good
agreement with the certied values for four different biolog-
ical CRMs. Gilon et al.64 compared LA-ICP-AES and LIBS with
conventional acid digestion and ICP-AES, for the determina-
tion of Ca, Mg, Na and Zn in milk powder. The laser ablation
results were biased by up to 60% due to a powerful matrix
effect.
4.4 Atomic uorescence spectrometry and vapour
generation procedures
It was impossible to discern any really novel development or
application relating to vapour generation techniques in the last
year. Simultaneous measurement of hydride forming and non-
hydride forming elements was mentioned in the previous
section. Mercury species in red wine were measured by GC-ICP-
MS aer derivatisation with 1% m/v NaBPh4 and the sum of
values compared with total Hg concentrations determined by
FI-CV-ICP-MS.65 However, when real samples of wine from
Argentina, Brazil, Chile and Uruguay were analysed, the Hg
species were below the LODs with total Hg being no more than
0.55 mg L1.
4.5 X-ray uorescence
4.5.1 In vivo XRF. The last year would appear to have been
a quiescent period with respect to in vivo XRF. A new instru-
ment was developed by Fleming et al.66 with a silicon PiN diode
detector and a miniature X-ray tube to excite L-line uores-
cence. This was tested by measuring Pb in plaster of Paris bone
phantoms. Models with varying amounts of added Pb were
used as the bare plaster or coated with either 1.2 or 2.7 mm
resin layers to simulate so tissue. The LODs obtained with
these samples were 7.4, 17 and 43 mg g1, respectively. The
sensitivity, therefore, is insufficient for the equipment to have
real application given that the typical concentrations of Pb in
bone found in other studies are less than 10 mg g1. An inter-
laboratory study for Pb in bone measurements was discussed
in Section 2. In a new application of in vivo XRF, Moise et al.67
measured Sr concentrations in nger and ankle bone (cortical
and trabecular bone, respectively) in an osteoporotic subject
prior to and then at intervals aer commencing oral treatment
with a daily dose of 680 mg Sr as strontium citrate. Baseline
concentrations were 0.38 and 0.39 mg g1 and increased
without reaching a plateau. Aer 800 days, the concentrations
were 7 and 15 times greater than at the pre-treatment time.
The K-alpha X-ray peak at 14.16 keV was used for these
measurements.
4.5.2 Quantitative analysis. Developments where XRF and
















































View Article Onlineare discussed in Section 5.2. While not exactly in vivo analyses,
investigations of ancient bone are not dissimilar to the work
required to validate and characterize the methodologies
described in the previous section. Human lumbar vertebrae
samples dating from the 10th Century AD were analysed by
Janos et al.68 using EDXRF. Bones from two sites in Hungary
were examined to measure concentrations of 12 elements.
Considerable post-mortem exchange between the soil and the
skeletal remains was evident for many of the elements but
concentrations of Br, Sr and Zn were thought to be consistent
with lifetime levels. Even older, fossil bones were examined,
also by EDXRF, by Thomas and Chinsamy.69 Noting the poorer
precision and larger bias associated with hand held devices,
they considered inter-sample trends in the EDXRF spectra
rather than measuring concentrations. Readings for elements
such as Ca, Fe and Sr were attributed to groundwater percola-
tion and it was suggested that the procedure employed may
assist with dening the original location of museum specimens.
Bones from living subjects, albeit collected at surgery, were
examined by micro-PIXE and PIGE to investigate the distribu-
tion and concentration of essential elements at the boundary
between bone and cartilage.70
Gherase and Fleming71 developed a method to calibrate XRF
measurements in nail clippings. Nail phantoms were prepared to
contain 0–20 mg g1 of As and Se. Clippings of 20, 40, 60, 80 and
100 mg were taken and X-ray emission spectra produced with a
portable X-ray tube. The XRF signal in a number of counts versus
elemental concentration was used to prepare calibration lines
for similar analysis of human nail clippings.
Zawisza and Sitko developed a strategy to determine Li in
mineral waters by XRF despite the poor uorescence and long
wavelength associated with such a light element.72 The method
involved forming a stoichiometric precipitate of a potassium
lithium periodatoferrate complex, re-dissolving and pipetting
onto Mylar foil for measurement of the Fe. The absolute
LOD for Li by this indirect approach was 1 mg. A report of a
preferred procedure to prepare biological samples prior to the
determination of elements with low Ar, by TXRF34 was included
in Section 3.2.
An equally simple method to measure concentrations of Gd
in urine and plasma by TXRF, in samples from patients given
Gd-based MRI contrast agents was reported by Telgmann et al.73
The LODs were 100 and 80 mg L1, respectively and the method
allows circulating levels and excretion to be monitored for up to
20 h post administration. Official catalogues of licensed medi-
cines, such as the British Pharmacopoeia, include specica-
tions relating to maximum allowable limits of possible
contaminants including metals. Antosz et al.74 published a
report that compared TXRF with other analytical techniques for
the determination of residual metals in active pharmaceutical
ingredients. These workers refer to the small sample size, short
analysis time and minimal matrix interferences associated with
TXRF, and also noted equivalent performance from instru-
ments with molybdenum or tungsten excitation sources.
Other interesting but straightforward applications of XRF to the
analysis of biological materials are included in Sections 5.3, 5.4,
6 and 7 and in the Tables.J. Anal. At. Spectrom.5 Applications: Clinical and biological
materials
Table 1 gives a summary of the work reviewed during this
period.5.1 Metallomics
Developments in metallomics and speciation is extensively
reviewed in a separate Update appearing in the August issues of
JAAS.6 This section is intended to give an indication of the range
of work relevant to clinical, biological interests, foods and
beverages from the last year.
Platinum-containing drugs are very effective in the treatment
of certain types of cancer but their use is complicated by
unpleasant side effects and by the development of resistance in
some patients. Resistance appears to be linked to the formation
of Pt–DNA adducts. Studies of the biochemistry of Pt in the cell
cytoplasm and nucleus can provide clues as to the mechanisms
of action of these drugs in individual subjects. To this end, the
work of Sharp and his colleagues is particularly relevant.
Methods were developed using HPLC with ES-MS and SF-ICP-
MS which allowed the identication of bi-functional Pt–dia-
minocyclohexane adducts involving oxaliplatin and mono- and
di-nucleotides with adenine and guanine, formed in vitro.75
Quantication of intra-strand DNA adducts with oxaliplatin in
cultured colorectal cells was also undertaken by SF-ICP-MS.75 In
further work with both cultured tumour cell lines and leuco-
cytes from patients treated with Pt-drugs, the distribution of Pt
within the cytoplasm and nucleus was determined.76
The complexity of metabolism of Se continues to become
more evident. With ultra performance-LC (UPLC), ICP-MS and
ES-linear-trap, Preud'homme et al.50 identied 49 compounds
involved in the metabolism of SeIV in yeast. These included
selenoorganic amino acids and oligopeptides at very low
concentrations and some previously reported structures were
re-interpreted on the basis of high resolution mass spectra and
mass accuracy associated with these techniques. In preparation
for an investigation of the metabolism of a Br-containing anti-
tuberculosis drug, Meermann et al.53 established a procedure to
separate Br species by HPLC-ICP-MS with on-line ID. Structural
information for the species was developed by ES-MS. Gold-
containing drugs have long been used in the treatment of
rheumatoid arthritis but their mode of action remains
unknown. Interactions with thiol compounds have previously
been suggested to be involved in the metabolism of these
compounds and Albert et al.52 worked with auranon to deter-
mine the nature of its binding to glutathione and albumin. The
data obtained using LC-ICP-MS and LC-ES-MS indicated
exchange mechanisms resulting in loss of the –SH group from
the parent drug and covalent bonding of the complementary
triethylphosphine AuI structure. Subsequent oxidation of the
phosphine ligand to form phosphine oxide may then take place.
Polyacrylamide gel electrophoresis is a regularly used
procedure for the separation of proteins within biological
samples. To identify and quantitate metalloproteins from
















































View Article Onlinetechniques may be used. Becker et al.77 separated extracted
protein from slugs by PAGE and, using LA-ICP-MS observed
three bands, corresponding to 75, 100 and 150 kDa, with
considerable Zn contents. Despite further work using MALDI-
TOF-MS and various databases, they failed to identify these
Zn-proteins. It is not oen that plant proteins feature in this
ASU and it is even more unusual to consider Cd in plants.
However, Polatajko et al.78 worked with a Cd-binding protein in
Cd exposed spinach plants. Following extraction and separation
by PAGE, a Cd-protein was located by LA-ICP-MS. From further
investigation by nano-ESI-FT ion cyclotron resonance MS, this
was identied as ribulose-1,5-biphosphate carboxylase/oxygen-
ase, an enzyme normally activated by Mg2+. Kutscher et al.79
proposed to measure the concentration of ovalbumin by adding
p-mercuribenzoic acid as a label and determining the Hg by
nanosecond LA-ICP-MS following PAGE. Quantication was
achieved by label-specic ID analysis with 199Hg-enriched label.
As in previous years, several procedures for speciation were
reported. Most were extensions to, or variations around,
established methods. Reference to these is shown in the Tables
while two of note are mentioned here. A novel material, nickel–
aluminium layered double hydroxide, provided a nano-sorbent
for the speciation of Cr and Mn in drinking water.80 The CrVI
and MnVII oxyanions at pH 6.0 adsorbed onto, or exchanged
with NO3
 within the sorbent interlayer. There was no retention
of CrIII and MnII. In an unusual application, Matsukawa et al.81
simultaneously measured concentrations of D- and L-SeMet
enantiomers in mouse plasma. The methodology required
purication of the SeMet by cation exchange chromatography,
addition of HCl to give the methyl ester followed by N-acylation
with (+)-a-methoxy-a-triuoromethylphenylacetyl chloride.
Separation and measurement were achieved by GC-MS with
selected-ion monitoring. The method was developed to allow
studies of the pharmacokinetics of the SeMet enantiomers.5.2 Applications for clinical and biological materials:
imaging with MS and X-rays
The eld of imaging using solid sampling techniques for the
analysis of biological materials has continued to grow. Three
review articles have succinctly summarised the application of
bio-imaging using advanced techniques.17,82,83 There remains to be
a strong focus on mass spectrometric based instrumentation,
with several publications reporting the development of new
technologies to aid imaging studies. A new LA chamber was
designed by Fricker et al.84 for ICP-MS which offered improved
washout times (within 2.6 s for 99.9% of the signal), high spatial
resolution on large samples (dimensions up to 230 mm 
34 mm  16 mm, L  W  D) and increased throughput for
small sized samples. Becker and colleagues85,86 have considered
the issue of handling large quantities of data which can be
generated during LA-ICP-MS analysis. A new soware tool85 was
developed to simplify the task of manipulating raw data, whilst
the use of k-means cluster analysis86 provided a method of
grouping specic tissue features and/or element proles to
compare across several tissue slices from an individual or a set
of individuals. Both of these tools offer ways to reduce the timeThis journal is ª The Royal Society of Chemistry 2013spent on data handling and to aid the identication of regions
of interest.
Calibration is an important consideration for quantitative
solid sampling analysis due to the strong matrix effect. It was
reported87 that homogenised rat brain, spiked with aqueous
elemental standards and encapsulated in a sol–gel matrix
generated by tetraethyl orthosilicate, created matrix-matched
biological standardswhichwere homogenous and stable at room
temperature for at least three months. Matusch et al.88 demon-
strated that meaningful quantitative analysis of human mesen-
cephalon slices stored in formalin for over 10 years was possible
byLA-ICP-MS forFe,MnandPbusingmatrix-matchedstandards.
The imaging of tissues can offer valuable insight into meta-
bolic pathways and disease states. Moreno-Gordaliza et al.89
reported the use of LA-ICP-MS tomap kidney tissue slices in rats
dosed with cisplatin to investigate Pt accumulation and neph-
rotoxicity. A novel use of iodine as a marker for single cells and
cell nuclei was demonstrated in broblast cells and liver tissue
slices.90 The authors further extended the method to apply I as
an internal standard for LA-ICP-MS to correct for tissue thick-
ness inhomogeneity when using lanthanide-based antibody
labels for the detection of breast cancer markers. The feasibility
of using enriched Zn isotopes as bio-tracers was demonstrated
by Urgast et al.91 using LA in combination with MC-ICP-MS to
create Zn isotope ratio images of rat brain tissue slices to
investigate Zn kinetics at the microscale.
Protein identication using gel electrophoresis for protein
separation in combination with LA-ICP-MS for element specic
detectionreceived signicant attention.Kutscheret al.79described
the quantication of ovalbumin labelled with p-hydroxy-mercu-
ribenzoic acid by external calibration using protein standards and
with ID analysis with a 199Hg enriched label, the latter offering
superior accuracy and precision. Two groups focussed on the
identication of plant proteins. Wu et al.92 reported the applica-
tion of 2D-PAGE to investigate the mechanisms of Cu tolerance
in the roots of Elsholtzia splendens.Using LA-ICP-MS as a detector,
the spots of metal-containing proteins were located, digested
with trypsin and analysed by LC-MS-MS for structural elucidation.
In a similar approach, Polatajko et al.78 used native anodal PAGE
and electroblotting onto membranes to screen for Cd-containing
proteins by LA-ICP-MS in Spinacia oleracea L. aer exposure to
Cd. Relevant bands of interest were trypsin-digested and analysed
by nano-ESI-FTICR for structural identication. Additionally, the
authors applied SEC-UV-ICP-MS to study metal-bound complexes
in the trypsin digests, making a very thorough investigation.78
X-ray uorescence offers a non-destructive alternative for bio-
imaging applications. This was demonstrated by the use of
SR-XRF to quantify and to determine the distribution of a
Gd-based MRI contrast agent in mouse liver samples.93 It was
tested with hepatitis infected tissues and displayed a reduced
uptake of the Gd agent when compared to controls, offering a
prospective new diagnostic test for this drug but also potentially
useful for pharmacological studies using exogenous elements.
Malinouski et al.94 employedSR-XRFmicroscopy to Se imaging in
mouse liver and kidney tissues, leading to the discovery of
localised pools of Se present as glutathione peroxidase 3. The use
















































View Article OnlineMg imaging in whole cells in combination with atomic force
microscopy. This allowed correction of uneven sample thickness
to produce concentration maps of intracellular Mg.
Two other works of note relate to less common imaging tech-
niques. Pineda-Vargas et al.96 applied micro-PIXE andmicro-RBS
to ngernails to build 3D quantitative elemental distributions
of major, minor and trace elements. The second publication97
reported the use of TEM and SIMS to investigate the migration
of Sm in the mammary gland of lactating Sm-dosed rats. The
combination of the techniques enabled the determination of
Sm levels and distribution within the cells.5.3 Multielement applications
5.3.1 Biological uids. Several interesting reports, apart
from determinations of reference ranges, were noted. Most were
concerned with relatively unusual sample types. Release of Cr and
Ni from orthodontic appliances into saliva was assessed by
Amini et al.98 using ETAAS. Samples collected from 28 subjects
with orthodontic appliances hadmean concentrations of 2.6 and
18.5 ng mL1 for Cr and Ni, respectively, while in samples from
same gender siblings without appliances concentrations were
2.2 and 11.9 ng mL1. The Ni, but not Cr, results were signi-
cantly higher for the test group. Kruger et al.99 provided a
comprehensive description of a method to analyse human
follicular uid using SF-ICP-MS. The procedure was used to
determine the concentrations of 24 elements in samples from 64
women undergoing in vitro fertilisation treatment. Analyses of
human bronchial lavage samples, in the context of occupational
exposure, have been cited in our recent ASUs. Suzuki et al.100
obtained similar samples from calves with mycoplasma bron-
chopneumonia infection and used PIXE to determine 18
elements. Compared with samples from healthy animals, there
were increased concentrations of Br, Ca, Fe, K, P and Zn, and also
a higher Zn : Cu ratio which was proposed as a diagnostic test.
Given that there is rarely a problem collecting sufficient
volume of urine for analysis, the work of Kumtabtim et al.101may
appear somewhat bizarre. Single droplets of urine, dried onto a
suitable support, were analysed by LA-ICP-MS. The concentra-
tions of 18 elements were determined with LODs of 0.003–
0.58 mg g1. The authors suggested that the procedure might
be applicable to forensic investigations when only a small
amount of dried urine was available.
Malavolta and colleagues30 developed a rapid procedure for
speciation ofCu, Fe, Se andZn in serumusing amonolithic anion
exchange microcolumn for HPLC-ICP-MS. Differences in speci-
ation results were seen with RMs from different sources. In an
unprecedented undertaking, 64 elements were determined in
140 serum samples by ICP-MS from patients with gouty arthritis,
and controls.102 Themeasured concentrations were then used to
develop a 12-element prole said to be unique to this condition.
This prole was subsequently tested with a further 39 patients
and 13 healthy controls and claimed to have a sensitivity of 1.00
and a specicity of 1.00, for prediction of gout. Such perfection is
almost unheard of in medical diagnostics.
5.3.2 Tissues, hair and nails. Font et al.103 determined Pb
and Sr isotope ratios in human head and facial hair to assessJ. Anal. At. Spectrom.whether these parameters relate to geographical location. It was
observed that changes in ratios rapidly reected movements of
the subjects between areas with different isotopic composition.
To assess whether formalin stored brain tissue may be used
with frozen samples, in order to investigate rare neurological
disorders, Matusch et al.88 prepared quantitative elemental
maps from brain slices stored for more than 10 years in buffered
formalin. Compared with a fresh sample, the distribution of Cu
and Zn within the substantia nigra had been lost but mean-
ingful assessments of Fe, Mn and Pb were possible with the
formalin xed samples. As discussed in Section 4.1, Becker and
colleagues continue to investigate quantitative elemental
mapping in tissues, especially in brain. Instead of their usual
LA-ICP-MS procedure, they have also employed laser micro-
dissection to isolate small areas of tissue (0.014 to 0.338 mg)
from mouse brain haematoma. The samples were digested and
analysed by ICP-MS using a micronebuliser-desolvation system
and it was found that concentrations of Fe, Na and Zn were 2 to
10 times higher than in normal tissue. The normal concentra-
tions of Al, Cu and Fe in aged brains were noted in Section 2.
As pointed out by Thomas and Chinsamy,69 bone chemistry
provides important information which may be of cultural as
well as physiological interest. However, very little novel work
was reported in the last year. Using handheld devices to
generate EDXRF spectra from fossil bone and tooth specimens,
and principal components analysis of the data, these authors
noted distinct differences in concentrations of Ca, Fe and Sr in
samples from two locations in South Africa. Bone and cartilage
was examined by Kaaber et al.70 in healthy and osteoarthritic
samples. Proton induced gamma-ray emission and micro-PIXE
were used to derive data on low Ar (z < 15) and heavier elements,
respectively. Normal cartilage contained signicant amounts of
Na and S while Zn concentrations were high at the bone carti-
lage interface.5.4 Progress for individual elements
5.4.1 Aluminium. It was something of a surprise to read
that drowning is still a difficult autopsy diagnosis. Researchers
continue to seek new analytical methods to aid diagnosis and
approaches have included the determination of trace elements
in blood as markers for drowning diagnosis. Aramendia et al.60
described a novel method for the determination of Al in whole
blood and water for exactly this purpose. Aluminium was
quantitatively determined by measurement of the molecular
absorption of AlF using HR-CS-ETA- molecular absorption
spectrometry. The AlF diatomic molecule was generated in the
furnace by reaction with NH4F$HF, which also improved
removal of the blood matrix for samples collected in EDTA or
heparin anticoagulant. Calibration was performed with
aqueous standards and an LOD of 1.8 mg L1 was reported. The
authors claimed that measurement of molecular absorption as
opposed to more conventional AA overcame most of the inter-
ferences experienced with the latter technique. The method was
used to determine Al in blood and drowning-water samples
from eight suspect cases of drowning and observed a signicant
positive correlation between Al in drowning-water and blood,This journal is ª The Royal Society of Chemistry 2013




presentation Sample treatment/comments Ref.
Al Blood, water —; —; — In an investigation of Al as a potential marker for drowning, a
procedure was developed to quantify Al by means of HR-CS
molecular absorption spectrometry, by measuring the molecular
absorption of AlF, formed in situ by addition of NH4F$HF, with an
LOD of 1.8 mg L1. Calibration was obtained with aqueous
standards, since NH4F$HF also promoted matrix removal
60
Al Erythropoietin AA; ETA; SEC Al present as a contaminant in erythropoietin formulations was
shown to be bound mainly to this protein, even in the presence of
human serum albumin, citrate or phosphate
104
Al Brain AA; ETA; L Al, Cu and Fe concentrations were measured in the temporal,
frontal, occipital and parietal lobes of 60 brains donated to the
Cognitive Function and Ageing Study, aer microwave aided
acid digestion. The median content was 1.02 mg g1 dw (Al),




AA; -; -; MS;
ICP; L
A survey of paediatric reference ranges applied in clinical
laboratories indicated wide variation
24
As Nails XRF; —; — A strategy for the calibration of a portable XRF instrument using
phantom nail clippings of increasing mass was reported
71
As Chinese medicines MS; ICP; L Morphological and microscopic characteristics of four Chinese
medicines containing As (orpiment, containing As2S3, realgar,
containing As4S4, arsenolite and arsenic trioxide, As2O3) were
proposed as a simpler and less costly method for their
authentication. The identity of arsenolite and arsenic trioxide was




AA; HG; FI To assess the risk of human exposure to As in areas of West
Bengal (India), samples of groundwater, locally grown foodstuffs
and urine were collected and analysed. The intake of As from
foodstuffs was estimated as 560 mg per day for adults and 393 mg
per day for children. The level of total As in urine ranged between
154 and 276 mg L1
107
As Urine MS; ICP;
HG/HPLC
In a longitudinal study of the exposure to As in rural Bangladesh,
the urinary As concentrations in 5 years old children (median:
51 mg L1, 5th–95th percentiles: 16–355 mg L1) were signicantly
correlated with those measured at 1.5 years old and to maternal
levels during gestation
108
As Blood, urine AA; HG; FI The speciation of AsIII and AsV was achieved by applying DLLME
to blood (5 mL) or urine (15 mL) samples. AsIII was complexed
with APDC at pH 4, followed by extraction and back extraction in
HCl prior to analysis. Total As was determined aer reduction of
AsV to AsIII with KI and ascorbic acid. AsV was determined by
subtraction. An LOD of 5 ng L1 was reported and an RSD of <5%
37
As Urine MS; ICP; HPLC 72Ge was used as a pseudo-isotope for As in order to apply “ID
type” analysis to the screening of As species in urine. On spiked
samples, recovery ranged from 90% to 115% and the RSD was
<10%. A comparison with the method of standard additions was
carried out
160
As Urine MS; ICP; HPLC iAs, MMA and DMA contributed to 75% of the total As
concentrations measured in urine from 153 residents in Latium
(Italy), chronically exposed to iAs via water and food.
Dimethylthioarsinic acid was found in 33% of the samples at





MS; ICP; HPLC As part of an investigation of As metabolism by microorganisms
from the human gut, ve As species (AsIII, AsV, DMAV, MMAV and
monomethylmonothioarsenate) were separated and quantied
by HPLC-ICP-MS, using a Hamilton PRP-X100 anion exchange
column. Two more species (MMAIII and DMAIII) were determined




MS; ICP; LC The metabolism of Auranon, a AuI-based drug, was explored by
LC-ESI-MS and LC-ICP-MS
52





















































presentation Sample treatment/comments Ref.
B Drinking water,
urine
AE; ICP; L In an area with high levels of naturally occurring B, the level of B
in public tap water ranged from 0.22 to 11.3 mg L1 and in bottled
water from 0.01 to 12.2 mg L1, compared with the WHO
guideline value of 2.4 mg L1. The B levels in urine of residents
was between 0.45 and 17.4 mg L1 (median: 4.28 mg L1) and was
correlated (r ¼ 0.64) with the corresponding levels in tap water
sampled from their homes
113
Be Tissues MS; ICP; L With the aid of a highmatrix interface, the determination of Be in
acid digested tissues by means of ICP-MS was achieved with an
instrumental LOD of 0.6 ng L1
43
Bi Water, hair AA; F; L Hair samples, washed with acetone and triply distilled water,
were digested with HNO3–HClO4, followed by 30% H2O2 and 1 M
H2SO4, then dissolved in water to a volume of 50mL. An aliquot of
10 mL of water or hair digest was subjected to DLLME using 5-Br-
PADAP as the complexing agent, acetone and dichlorobenzene.
Phases were separated by centrifugation and the bottom phase
diluted with EtOH prior to analysis. An enrichment factor of 28.6
was reported. The LOD was 3.0 ng mL1 and the RSD was 1.5%
111
Bi Serum AE; ICP; L An enrichment factor of 81 was achieved by cloud point extraction
of Bi3+ with 8-hydroxyquinoline and Triton X-114. An LOD of
0.12 mg L1 was obtained. The RSD was 2.3% and recovery was
between 92.3% and 94.7%
112
Br Faeces MS; ICP; HPLC A method was developed to quantify metabolites of a Br-
containing anti-tuberculosis drug in faeces by means of on-line
ID, in combination with ESI-MS for their structural identication
53
Cd Urine MS; ICP; L A novel application was reported for the determination of urinary
proteins via a CdTe quantum dots label. The LOD for human
albumin was 0.008 mg mL1
54
Cd Human milk AA; —; L The geometric means of the concentration of Cd, Hg and Pb
in breast milk from a sample of 100 Spanish women were
1.31 mg L1, 0.53 mg L1 and 15.56 mg L1, respectively. Smoking
and dietary habits were the main contributing factors
144
Ce Human milk MS; ICP; L Ce concentrations were measured in human milk samples and
paired serum samples from lactating women in Munich
(Germany) and Madrid (Spain). No evidence of transfer from
blood to milk was found
121
Cr Saliva AA; —; —; L A retrospective study compared the levels of Cr and Ni in saliva
from 28 subjects who had undergone xed orthodontic therapy
for 12–18 months with those observed in their same gender
siblings selected as controls. A signicant difference was
observed for Ni levels, but not for Cr concentrations
98
Cr Plasma, red blood
cells, urine, hair
MS; ICP; L The toxicokinetics of Cr in a case of accidental poisoning was
followed by monitoring Cr concentrations in biological uids, red
blood cells and hair for 49 days. Evidence of in vivo Cr absorption
into red blood cells and possibly other cells emerged
114
Cu Kidney MS; ICP; LA The distribution of Cu, Pt and Zn in kidney from rats treated with
cisplatin was determined as part of an investigation of Pt




AA; —; —; L An indirect method to determine adrenaline concentration in
pharmaceutical and serum samples was reported, based on the
reduction of CuII to CuI by adrenaline at pH 6.0, the subtraction of
CuI from the solution by reaction with SCN to form CuSCN and
the subsequent measurement of the remaining CuII. The LOD
was 0.033 mg mL1 and the RSD was 0.56%
116
Cu Brain AA; ETA; L See Al, ref. 28 28
Cu Tissue MS; ICP; L To assess the contribution of impaired Cu homeostasis to the
oxidative stress in Alzheimer's disease (AD), post-mortem cortical
tissue samples from AD cases and elderly controls were analysed
for total Cu content, labile Cu concentration and capacity to
stabilize Cu2+
115





















































presentation Sample treatment/comments Ref.
Cu Serum MS; ICP; L Based on a total of 2115 American, clinically healthy, children,
mainly Caucasian, aged 0.5–18 years, reference ranges were
proposed for serum Zn as 64–124 mg dL1 and for serum Cu as
75–153 mg dL1 (for children aged <10.3 years), 64–132 mg dL1
(for those aged between 10.3 and 12.5 years) and 57–129 mg dL1
(for children older than 12.5 years)
25
Fe Mineral water XRF; —; — A clever sample pre-treatment, the precipitation of the
stoichiometric K Li periodatoferrate complex, allowed to quantify
trace amounts of Li, down to 1 mg, via the analytical
determination of the more favourable element, Fe
72
Fe Brain AA; ETA; L See Al, ref. 28 28
Gd Urine, blood
plasma
XRF; —; — The determination of Gd was performed in urine and plasma
samples from patients given Gd-based contrast agents prior to
MRI and the results compared with those obtained by ICP-MS.
LODs were 100 mg L1 in urine and 80 mg L1 in blood plasma,
respectively
73
Gd Blood, tissues XRF; —; — In ratmodels, Gd showed a rapid disappearance in blood,
followed by a rapid and time-dependent accumulation in the
liver. Bile was conrmed as the main elimination route for a
Gd-based MRI contrast agent
93
Hg Proteins MS; ICP; LA A novel approach, based on label-specic IDA, was applied to
quantify ovalbumin labelled with 199Hg enriched p-hydroxy-
mercuribenzoic acid aer PAGE. The LOD was 160 fmol
(ovalbumin) and recovery was between 95% and 103%
79
Hg Human milk AA; —; L See Cd, ref. 144 144
Hg Blood MS; ICP;
GC AA; —; L
To determine the concentration of MeHg, blood samples (150 mL)
were extracted with 6MHCl–NaCl, followed by derivatisation with
NaBPh4 and extraction into hexane, prior to analysis by GC-ICP-
MS. The LOD was 86 ppt (as Hg). Total Hg was determined by AAS
using the amalgamation technique
161
Hg Urine AA; CV; L The results obtained, in mining areas in Zimbabwe, Indonesia
and Tanzania, with portable mercury analysers, based on
reduction with SnCl2, were approximately 25% lower than those
obtained on the same sample with laboratory equipment, using
NaBH4
119
Hg CRMs —; —; — A review of the currently available environmental and biological
CRMs for Hg speciation was presented
13
Hg Brain MS; ICP; L MS;
ICP; HPLC
The mean concentrations of MeHg in brain from 24 polar bears
were: 0.28  0.07 mg kg1 dw (frontal lobe), 0.23  0.07 mg kg1
dw (cerebellum) and 0.12  0.03 mg kg1 dw (brain stem)
162
Hg Saliva AFS; CV; — A novel procedure, solidied oating organic drop
microextraction, was applied for the pre-concentration of Hg
from saliva samples. The DDC–Hg complex was extracted into
1-undecanol, which, aer cooling in an ice bath, solidied in a
microdrop. An enrichment factor of 182 was achieved from a
25 mL sample. The LOD was 2.5 ng L1 and the RSD at
0.1 ng mL1 was 4.1%
36
I Single cell MS; ICP; LA LA-ICP-MS was applied to imaging of single cells and cell nuclei




MS; ICP; L Over a period of 5 years, the content of I in cow (135) and human
(65) milk samples in Thuringia (Germany), determined by ICP-MS
aer digestion with TMAH, remained stable
145
In Urine AA; ETA; L Aer testing Amberlite IRC-50, Duolite GT-73 and Celite 545-AW,
the pre-concentration of In from 100–200 mL urine samples was
achieved by retention on 1.2 g of wet Chelex-100, followed by
elution with 5.0 mL of 0.1 M HNO3, with an LOD of 2.75 ng mL
1
163
La Serum MS; ICP; L A method was developed to measure serum La concentration in
patients with chronic kidney disease administered with
La2(CO3)3. The LOQ was 0.1 mg L
1
122
Li Mineral water XRF; —; — See Fe, ref. 72 72





















































presentation Sample treatment/comments Ref.
Mg Whole cells XRF; —; —,
AFM; —; —
A novel approach was reported, combining XRF microscopy and
AFM, to obtain a concentration map for Mg in whole cells
95
Mn Blood, plasma MS; ICP; L Modied skimmer cones were more successful than a collision
cell to eliminate the FeH interference at mass 55 for the
determination of Mn in blood and plasma samples, diluted with
0.005% Triton X-100, 0.2% propan-2-ol, 0.2% butan-1-ol and 1%
HNO3
48
Ni Saliva AA; —; —; L See Cr, ref. 98 98
P Liposomes MS; ICP; CE The simultaneous determination of P and Pt by means of CE-ICP-
MS with Ar as the collision gas allowed to characterise a liposome-
based formulation of oxaliplatin. The LOD was 29 ngmL1 Pt and
the RSD was 2.9%. A comparison was carried out with ICP-MS
aer microwave aided digestion
120
Pb Blood MS; ICP; L An investigation of Pb isotopic ratios in environmental and blood
samples allowed discriminating suspected sources of exposure in
French children
164
Pb Bone XRF; —; — An LOD of 43  7 mg Pb g1 was achieved for the in vivo
determination of Pb in bone using a miniature X-ray tube with a
silicon PiN diode detector
66
Pb Roman medicines XRF; —; — Pb and Zn salts and other organic substances were identied in
residues from medicine containers from Roman times analysed
by GC-MS, XRF and Raman spectroscopy
165
Pb Blood, hair, tissues MS; ICP; L The performance of a method for the simultaneous
determination of both Pb concentration and isotope ratios
(204Pb : 206Pb, 207Pb : 206Pb and 208Pb : 206Pb) in biological
samples from exposed rats were reported. The concentration of
Pb was calculated as the sum of all isotopes. The highest Pb
concentration was in femur, followed by kidney, hair, liver and
blood
166
Pb Human milk AA; —; L See Cd, ref. 144 144
Pb Bone XRF; —; —,
AA; ETA; L
The accumulation of Pb in bone was studied in an animal model
(Wistar rats) exposed to Pb from birth
167
Pb Bone XRF; —; —;
MS; ICP; L
XRF measurements of Pb performed by different laboratories on
the same nine goat tibiae were compared with ICP-MS
determinations
20
Pb Blood, bone XRF; —; — Pb levels in blood and bone were found to be associated with
several markers of cardiovascular disease, including tumour
necrosis factor receptor-2, total cholesterol and HDL levels
168
Pb Blood, plasma MS; ICP; L The kinetics of Pb in blood and plasma was studied in 5 cases of
lead poisoning
169
Pb Hair MS; ICP; L Three procedures for removing external Pb and Sr contamination
from hair samples were compared. They were: centrifugation with
diiodomethane; leaching with 2 M HNO3 and washing with
chloroform, MeOH and ultra pure water. Pb and Sr isotope ratios
in scalp and facial hair were investigated in relation to
geographical movements, in both archaeological remains and
modern subjects
103
Pb Teeth MS; ICP; LA The value of measurements of Pb in dentine was investigated by
combining information of the spatial distribution of Pb with




MS; ICP; L A micro-column packed with commercial thioureidopropyl
functionalised silica gel was used for the pre-concentration of Pd
and Pt from urine, serum and PM10 airborne particulate matter
fraction samples, followed by microwave assisted elution with
0.5% thiourea. LODs of 0.2 ng L1 and RSDs between 1.3% and
11.0% were achieved
40






In vitro studies of adducts of oxaliplatin with mono-nucleotides,
di-nucleotides and cellular DNA were carried out using HPLC
with both UV detection and coupled with SF-ICP-MS or ESI-MS. Pt
was detected at concentrations as low as 0.14 ppb (0.22 Pt adduct
per 106 nucleotides, based on a 10 mg DNA sample)
75
and 76





















































presentation Sample treatment/comments Ref.
Pt Tissues, plasma MS; ICP; L,
AA; —; L
The levels of carboplatin–DNA adducts, measured in clinical
samples removed 6 h aer drug administration, ranged from 1.9
to 4.3 and 0.2 to 3.6 nmol Pt g1 DNA for ovarian tumour biopsies
and peripheral blood mononuclear cells, respectively. The
reliability of the approach was validated on experimental animals
170
Pt Liposomes MS; ICP; CE See P, ref. 120 120
Pt Environmental and
biological samples
MS; ICP; L See Pd, ref. 40 40
Pt Plasma, tissues MS; ICP; L The pharmacokinetics of a novel anticancer drug, dicycloplatin,
was investigated in experimental animals
171
Rb Urine MS; ICP; L In a study involving 240 women with incident invasive breast
cancer before their treatments and 246 age-matched female
controls, urinary levels of Rb were signicantly and inversely
associated with risk of breast cancer
123
S Brain XANES; —; — 2D-imaging of S species in tissue sections highlighted the
presence of different (2, 4+ and 6+) oxidation states
172
Sb Plasma, tissues MS; ICP; L MS;
ICP; HPLC
The pharmacokinetics of meglumine antimoniate was
investigated in monkeys. Sb levels were determined in timed
collections of plasma as well as in tissues aer sacrice. The drug
half-life was 35.8 days. Sb levels >1000 ng g1 were found in
thyroid, nails, liver, gall bladder and spleen
106
Sb Hair, nails, teeth —; —; — A review of literature data conrmed the usefulness of hair Sb to
monitor occupational exposure, but not as an index of health





MS; ICP; LC MS;
ICP; LA
The content of three selenoproteins (selenoprotein P, glutathione
peroxidase 3 and selenoalbumin) was quantied using a
combination of affinity LC-ICP-MS with on-line ID, LA-ICP-MS
and MS/MS
23
Se Nails XRF; —; — See As, ref. 71 71
Se CRMs, serum MS; ICP; HPLC As a follow-up of a previously reported study for the quantication
of SeMet by a primarymethod (species-specic ID-HPLC-ICP-MS),
an investigation of the three main uncertainty sources was
reported
19
Se Liver, kidney XRF; —; — The distribution of Se in mouse liver and kidney was assessed by
HR SR-XRF microscopy. A highly localized pool of Se at the
basement membrane of kidneys was associated with glutathione
peroxidase 3
94
Se Proteins MS; ICP; SEC As part of investigations of a possible role of Se in the onset of
cerebral vasospasm, metallomics techniques, including LC-
MALDI-TOF/TOF and SEC-ICP-MS were applied to explore the
proteome associated with the disease
51
Se Urine MS; ICP; LC An investigation of the urinary excretion of selenite and selenate,
enriched with 82Se, given orally, highlighted differences in the
metabolic pathways of these two Se species, with average
excretions within 24 h of 33.7% selenate vs. 3.2% selenite
124
Se Plasma MS; ICP; HPLC Heparin affinity chromatography used in combination with SEC
allowed the retention of 90% of selenoprotein P from both and





MS; ICP; L The difference in Si concentration in whole blood from the le
and right ventricles was reported as a marker of freshwater
drowning. Si concentrations were determined by DRC-ICP-MS,






An investigation of the localization of Sm inmammary gland cells
from lactating Wistar rats treated with Sm and controls indicated
the preferential deposition of Sm in the epithelial cell lysosomes
97
Sr Hair MS; ICP; L See Pb, ref. 103 103
Sr Bone XRF; —; — Sr uptake in bones of an osteoporotic woman administered Sr
citrate was monitored by means of XRF
67





















































presentation Sample treatment/comments Ref.
Ti Serum MS; ICP; L MS;
ICP; LC
ID-double focussing-ICP-MS, with a medium resolution of
4000, was applied for the determination of the concentration
of Ti in serum samples from 40 unexposed subjects (average
concentration of 0.26 mg L1) and patients with Ti-based
implants. The LOD was 0.05 mg L1. A study of the in vivo
transport of Ti in serum by anion-exchange LC coupled
on-line with double focussing-ICP-MS, using post-column
ID for quantication, showed that 99.8% of the Ti present
in serum was bound to transferrin
27
Ti Blood AA; ETA; L The test samples were diluted 1+4 with 0.1% (m/v) Triton X-100. A
chemical modier, 200 mg NH4NO3–160 mg Pd(NO3)2, was used.
An LOD of 0.2 mg L1 was achieved. The working range spanned
from 2 to 50 mg L1 and the RSD was <12%
125
U Tissues TIMS; —; — The concentrations of 234U, 235U, 236U and 238U and the isotopic
ratios 234U : 238U, 235U : 238U and 236U : 238U were determined in
20 human tissue samples from a deceased subject, formerly
occupationally exposed to U
56
U Urine MS; ICP; L U levels in 24 h urine samples from volunteers of both genders,
aged from 3 to 78 years, living in Southwest Nigeria, were
determined. The median values for daily excreted U were 14.2 ng
per day for adults and 45.1 ng per day for children, respectively,
and were comparable to reference values for unexposed subjects
in other countries
126
U Hair MS; ICP; L The effect of external contamination was assessed by submitting
hair samples from six adult volunteers to washing with water
containing high levels of natural U. In the hair samples, cleaned
according to widely used procedures before analysis, the U
concentrations were about three orders of magnitude higher than
in the original samples
127
Zn Slug tissue MS; ICP; LA The distribution of Zn-containing proteins was mapped in whole
tissue and in the proteins bands separated by one dimensional
gel electrophoresis
77
Zn Kidney MS; ICP; LA See Cu, ref. 89 89
Zn Roman medicines XRF; -; - See Pb, ref. 165 165
Zn Serum MS; ICP; L See Cu, ref. 25 25
Various (6) Biological CRMs XRF; —; — The analytical capabilities of TXRF for the determination of low z
elements (Ca, K, Mg, Na, P and S) in biological matrices were
tested on CRMs aer microwave assisted acid digestion.
Additional preparation methods (direct analysis, microwave
assisted acid digestion in micro-vessels, vapour-phase digestion




XRF; —; — XRF-CT computed tomography was applied to the non-
destructive imaging of the trace element distribution in
biomedical samples, even of large size
175
Various (20) Blood MS; ICP; L The expanded uncertainty of the results obtained by means of
SF-ICP-MS ranged from 11% to 26%. LODs were between
0.0015 mg L1 and 1.03 mg L1
18
Various (20) Blood MS; ICP; L Concentrations of 20 elements were determined in blood
samples from Italian adolescents, aged 13–15 years, by
means of SF-ICP-MS
26
Various (4) Blood MS; ICP; L Although largely recognised as a problem in the past,
contamination of blood samples with Co, Cr, Mn and Ni from
collecting devices was explored again
29
Various Bone XRF; —; — Investigations of the elemental compositions of fossil
bone and tooth specimens were performed with portable
EDXRF spectrometers. To overcome the reduced accuracy
of these instruments, statistical methods were applied,
such as normalisation and mean centering of spectral
data, before PCA
69





















































presentation Sample treatment/comments Ref.
Various (12) Bone XRF; —; — The concentrations of Al, Br, Ca, Cl, Fe, K, Mg, Mn, Na, P, Sr and
Zn were determined by EDXRF in bone samples from two burial
sites from the 10th century AD. The results highlighted post-
mortem environmental inuences on the composition of bones
as well as enhanced levels of Br and Sr accumulated during the
past life
68
Various Bone, cartilage PIXE; —; —,
PIGE; —; —
The distribution of trace and essential elements in human
femoral head sections was investigated by PIGE (atomic number




MS; ICP; L A system combining a small-bore PTFE sample loop,
microdialysis sampling, on-line automatic in-loop SPE and
ICP-MS was developed and its capabilities tested on CRMs
and samples of brain extracellular uid. LODs ranged from
0.003 to 0.5 mg L1
31
Various Brain tissue MS; ICP; LA Human mesencephalon slices from a single subject, stored in
formalin for more than 10 years, were analysed to provide
information on elemental distribution
88
Various Brain tissue MS; ICP; L To obtain maps of elemental distribution, small samples (from
0.014 to 0.338 mg) were obtained from selected brain areas by
laser microdissection and digested in a closed vessel microwave
oven prior to analysis
176
Various Brain tissue MS; ICP; LA The technique capability to provide multielement information
was exploited using specic data handling strategies and soware
86
and 85
Various (8) Brain tissue MS; ICP; LA The preparation of stable matrix-matched standards, based on
ground rat tissue, spiked with the elements of interest and





PIXE; —; — Out of 18 elements measured in bronchoalveolar lavage uid
samples from Holstein calves with mycoplasma
bronchopneumonia (n ¼ 21) and healthy controls (n ¼ 20), the
concentrations of Br, Ca, Fe, K, Mg, P and Zn were higher in
diseased calves than in controls. The Cu : Zn ratio was proposed
as a diagnostic aid
100
Various CRM Bovine liver MS; ICP; L An improved sample introduction system, consisting of the
combination of an inert loop injection unit with a high
performance concentric nebuliser coupled with a temperature
controllable cyclone chamber, allowed to introduce 20 mL
samples in a carrier liquid ow of 10 mL min1, achieving the
same sensitivity as conventional nebulisers
44
Various (6) Gastric extracts AE; ICP; ETV ETV was applied to enhance the sensitivity of the determination
of Ba, Co, Cu, Mn, Ni and Pb as part of an investigation of the
bioavailability of these elements from airborne particulate
matter. 700 mg synthetic gastric juice were added to four 12 mm
diameter aliquots of each lter, corresponding to about 14.4 m3
air. The sample was sonicated, then centrifuged. 40 mL of the
exctract were placed in a graphite boat, dried in a laminar ow
box using an infra-red lamp, then inserted in the graphite tube for
analysis. LODs, determined on blank lters, ranged from 1.8 ng
(Mn) to 12.2 ng (Cu) which corresponded to method LODs from
0.11 ng m3 (Mn) to 0.75 ng m3 (Cu). The RSD% varied from
1.9% (Cu) to 5.7% (Ni)
62
Various (5) Hair AA; F; L The concentrations of Ca, Cu, Fe, Mg and Zn were determined in
hair samples from 77 women aged 35.9 9.7 years and compared
with their daily intake of minerals
177
Various (17) Single hair strands MS; ICP; LA Using a novel strategy, CRMs or in-house prepared matrix
matched standards could be analysed under the same conditions
as test samples, thus improving the quantication of As and 16
other elements and the detection of exposure time proles. The
LOD was 0.6 mg g1 for As and ranged from 0.3 to 7.8 mg g1 for
the other elements
55





















































presentation Sample treatment/comments Ref.
Various (24) Human follicular
uid
MS; ICP; L Aer optimisation of analytical procedures for both Q- and
SF-ICP-MS, 72 human follicular uid samples were analysed
99
Various (4) Human milk AA; —; L The concentrations of Cu, Mn, Se and Zn were measured in
samples of humanmilk from Korean mothers of pre-term babies,
collected over a period of 12 weeks post-partum. Both Se and Zn
levels met the recommended daily requirements, whereas Cu
intake from milk was lower and Mn intake higher
143
Various (5) Muscle, bone AE; ICP; L The concentrations of Cu, Fe and Zn, measured in themuscle and
bone tissues from the tail of an alligator (Alligator mississippiensis)
were reported. Cd and Pb levels were below the LOD (0.5 mg g1)
of the technique
155
Various Nails PIXE; —; — 3D elemental concentration maps of individual ngernails were




XRF; —; —, MS;
ICP; L
TXRF was applied to the determination of metals, present as
contaminants, in active pharmaceutical ingredients and
intermediates. A comparison with ICP-MS was carried out for Cu
and Pd determinations
74
Various Proteins MS; ICP; LA A newly developed ablation cell for high spatial resolution
analysis was tested on a protein sample aer PAGE
84
Various (4) Serum MS; ICP; HPLC The separation of Cu, Fe, Se and Zn species in 1 mL serum was
achieved using monolithic anion exchange micro-columns and
tandem HPLC-ICP-MS. The use of EDTA as anticoagulant was
shown to inuence the speciation of Fe and Zn
30
Various (64) Serum MS; ICP; L Out of 64 elements measured in serum samples from patients
with gouty arthritis (n ¼ 100) and age-matched controls (n ¼ 40),
the concentrations of Al, Bi, Cu, Fe, Hg, Li, Se, Sr, Ta, Th, Ti and U
were signicantly altered in patients
102
Various (12) Tissues, CRMs XRF; —; — Three sample preparation procedures were compared for the
determination of As, Ca, Cr, Cu, Fe, K, Mn, Ni, P, Se, Sr and Zn by
TXRF. Ultrasound-assisted extraction with a mixture of 10% v/v
HNO3–20–40% v/v HCl provided the best LODs
178




Combined isotope measurement of C, N, O and S, by continuous
ow isotope ratio-MS (CFIRMS), and of Sr, by means of TIMS, in
human remains from a medieval Scottish village gave data from
which information on their dietary habits and their capability to
grow crops could be deduced
179
Various Urine MS; ICP; LA The determination of several elements was achieved in a single
droplet of urine, dried on supports such as Teon sheets,
Whatman 903 lter paper and glass slides, with LODs ranging
from 0.003 to 0.58 mg g1
101
Various (5) Urine MS; ICP; L The urinary levels of Be, Cd, Te and W were increased and that of
Pb decreased in athletes vs. sedentary subjects
180
Various (5) Urine RM MS; ICP; L An alternative sample introduction system, a dual drop-on-
demand aerosol generator, and a calibration strategy based on
the dosing frequency were applied to the determination of Cs, Li,

















































View Article Onlinewhich led them to argue the appropriateness of blood Al
determination as a marker for diagnosis of drowning.
It is pertinent to highlight concerns still raised over the
validity of published reference ranges for trace elements. In
response to concerns over the effect of low level Al exposure on
childhood development, Zeager and colleagues24 conducted a
study to obtain information from clinical laboratories on refer-
ence ranges for Al in plasma, serum and urine. Signicant vari-
ations were noted both in the ranges reported by the seven
participating laboratories and in the ranges determined using
different analytical techniques. For laboratories using AAS, the
ranges varied from<5mg L1 to <20mg L1 for serum, <7mg L1 toJ. Anal. At. Spectrom.0–10 mg L1 for plasma and 5–30 mg L1 for urine, whilst,
for laboratories using ICP-MS, values ranged from 0–6 mg L1 to
<42 mg L1 for serum, 0–10 mg L1 to 0–15 mg L1 for plasma and
0–7 mg L1 to 5–30 mg L1 for urine. Perhaps more importantly,
the authors noted that no ranges reported were known to be
derived from studies of healthy infants and were developed from
small-scale studies of either adult populations or sick children
on parenteral therapy. The group concluded that further studies
on Al concentrations in children were warranted in order to
obtain data representative of a healthy infant population.
Erythropoietin (EPO) is used clinically to treat anaemia in
















































View Article OnlineUnfortunately, many EPO formulations are contaminated with Al.
Viega et al.104 coupled SEC with ETAAS to study the binding of Al
to protein species in EPO formulations. With optimised
conditions to separate EPO from serum albumin (also present
as a major protein species), the authors quantitatively deter-
mined Al in 1 mL aliquots of the column eluate and established
that Al was only associated with the fractions corresponding to
the EPO peak. The researchers also examined the inuence of
temperature on Al binding to EPO and reported that the binding
was three-fold higher at 37 C than at 4 C. In formulations
containing 11 mg mL1 EPO, approximately 50% of the Al was
not ultralterable, from which they concluded that EPO was a
very effective acceptor for Al.
5.4.2 Antimony. Filella et al.105 presented a critical review of
the determination of Sb in hair, nails and teeth. Their assessment
focused on methodological approaches and the possibility of
establishing reference ranges for Sb in these matrices. It was
noted that the published data suffered from the lack of adequate
CRMs to validate measurements and that many methods were
insufficiently sensitive for quantitative determination of the
element in these matrices. The researchers considered these
limitations were responsible for the wide dispersion of pub-
lished values and proposed a ceiling reference value of 0.1 mg g1
for Sb in human hair. Despite these limitations and the well-
recognised problem of external contamination of this sample
type (see Section on Uranium), the authors concluded that the
measurement of Sb in human hair was a useful method for
monitoring occupational exposures to the element.
What is more certain is the efficacy of Sb treatments for
leishmaniasis. A Brazilian group106 examined the tissue deposi-
tion and elimination kinetics of Sb in monkeys infected with
Leishmania braziliensis and administered low (5 mg SbV kg1
body weight per day) and standard (20 mg SbV kg1 body weight
per day) doses of meglumine antimoniate. Levels of Sb in
various tissues were determined using ICP-MS whilst IC
coupled with ICP-MS was used to determine Sb speciation in
plasma. Maximum plasma Sb concentrations were 27.4 ng g1
and 95.7 ng g1 for the low dose and standard dose groups
respectively. Plasma Sb levels declined with a half-life of 35.8
days and the proportion of Sb as SbIII rose from 5% to 50%
during the rst 9 days post-treatment. Tissue concentrations of
Sb were highest in liver, thyroid, gall bladder and spleen. The
authors considered that both the accumulation of Sb in these
target organs and possible patho-physiological consequences of
this accumulation were areas for further research.
5.4.3 Arsenic. Concerns over the high prevalence of chronic
arsenicosis in regions of the Indian sub-continent do not appear
to have abated if one considers the number of papers reporting
on human exposure to As in these regions during this review
period. The following papers suggest that the mitigation strate-
gies put in place are not effective and that high exposures persist.
Samal et al.107 used FI-HG-AAS to determine As in groundwater
and locally grown crops and vegetables from the Bengal delta
region, whilst exposure to As was assessed by determining As in
urine using the same analytical technique. The researchers
measured exceptionally elevated concentrations in rice crops
(194 mg kg1 and 156 mg kg1 in two different rice species) andThis journal is ª The Royal Society of Chemistry 2013estimated adaily As intake of 560mgper day for adults and393mg
per day1 for children, which was supported by the levels of As
determined in urine samples (154–276 mg L1). The authors
concluded that more action was needed to be taken to control
contamination of the local food supply and thus protect the
population who are consuming these foods. Gardner et al.108
reported the ndings of a longitudinal study of As exposure in
mother–child pairs from rural Bangladesh. The mothers were
monitored in early gestation and subsequently with their chil-
dren through to ve years post-partum. Urine As concentrations
were quantitatively determined using HPLC coupled on-line
with HG-ICP-MS. Children at ve years had elevated levels of As
(16–355 mg L1) and these showed a signicant positive correla-
tion with levels at 1.5 years and to maternal concentrations in
early gestation. The results led the researchers to conclude that
exposure to As remained high despite the mitigation strategies
that had been introduced to date. The group proposed that
further strategies need to be adopted and rigorously monitored
and evaluated. The Indian sub-continent is not the only region
that suffers from high environmental As levels. Cubadda et al.109
investigated urinary As excretion in an adult population living in
Latium,Central Italy, a regionwhich alsohas elevated levels of As
in groundwater and locally grown produce. The researchers
rightly re-emphasised the fact that total urine As is not suitable
for biological monitoring of iAs exposure. Five As species were
quantitatively determined in urine using gradient elution anion
exchange HPLC-ICP-MS. Relative proportions of the major
species were iAs 14%, MMA 13% and DMA 72%. Total As levels
ranged between 2 and 72 mg L1. The dimethylthioarsinic acid
species was also detected in 33% of the samples analysed at
concentrations ranging from trace levels to 6 mg L1.
One of the more important papers on As speciation pre-
sented over this review period was that of Alava et al.110 The
group were interested in how the gut microora inuence As
metabolism in humans and, to investigate this, they developed a
simulated human intestinal microbial environment. A combi-
nation of anion exchange HPLC with ICP-MS was developed to
separate and quantitatively determine AsIII, AsV, DMAV, MMAV
and monomethylmonothioarsenate, whilst a C18 column was
used to separate MMAIII and DMAIII species. The methods were
used to determine As species in suspensions sampled from the
in vitro simulator and also in vivo from faeces and samples taken
from the human colon. A second group58 undertook a series of
in vitro experiments to study the synthesis of possible inter-
mediates of As metabolism. In particular, the researchers
investigated the reaction of methylated As species with
biomolecules such as glutathione and S-adenosylmethionine
through protein thiol–As bonds. The As species generated by
the in vitro reactions were identied using ESI-MS and HR-MS
and from the results obtained they hypothesised a number of
non-enzymatic chemical reactions that may play a role in
intracellular As metabolism. One might question whether these
reactions monitored in vitro truly reect in vivo metabolic
reactions or are simply artefactual consequences of the partic-
ular conditions employed in the experiments.
5.4.4 Beryllium. The quantitative determination of trace
















































View Article Onlineinvolves some form of sample treatment to pre-concentrate Be
from the samplematrix prior tomeasurement of the element. In
an effort to avoid the need for element pre-concentration, Lar-
iviere et al.43 combined a high matrix interface conguration
with internal standardisation to quantitatively determine Be in
diluted samples of human autopsy tissue digests. Optimisation
of the interface conguration enabled the system to dealwith the
high salt and dissolved solids within the digested samples and
gave a reported 2.7-fold improvement in LOD (0.6 mg L1). The
method was validated by determining Be concentrations in hair
and blood CRMs. The authors used the method to determine Be
levels in autopsy samples from the US trans-uranium and
uranium register. Beryllium concentrations between 0.015 and
255 mg kg1 were reported for the autopsy samples analysed.
5.4.5 Bismuth. Recent ASU reviews have reported on trace
element pre-concentration procedures based on liquid–liquid micro-
extractionmethods. Two research groups reported suchmethods
for thepre-concentration andquantitative determinationof Bi in
biological matrices. Fayazi et al.111 used 2-(5-bromo-2-pyr-
idylazo)-5-(diethyl amino)phenol as the complexing agent with
acetone and dichlorobenzene as the dispersing and extracting
solvents respectively for the extraction of Bi3+ followed by
determination using FAAS. Using optimised concentrations of
complexing agent and extraction solvent, the researchers
reported anenrichment factor of 28.6 giving anLODof 3ngmL1
withRSDof 1.5%at 0.4 mgmL1. The authors used themethod to
determine Bi in a range of natural and spiked biological mate-
rials. For the cloud-point extraction of Bi from human serum,
Sun andWu112 used 8-hydroxyquinoline as the complexing agent
and Triton X-114 as the ionic surfactant. The authors optimised
extraction conditions to achieve an 81-fold enrichment factor
from an initial 25 mL sample volume. This does, however, seem
to be a rather excessive blood sample volume to be taken from
human subjects. The concentration of Bi3+ in extracts was
determined using ICP-AES. An LOD of 0.12 mg L1 was reported.
5.4.6 Boron. The WHO guideline value for B in drinking
water (0.5 mg L1) is designated as provisional because of the
difficulty in achieving it in areas of high natural B levels. The
pertinence of this statement is exemplied in the work under-
taken by Cortes et al.113 The researchers determined levels of B
in tap and bottled water from a region of Northern Chile and
corresponding levels of B in urine from a volunteer population
drinking this water. Urine and water concentrations of B were
determined using ICP-AES. Levels of B in tap water ranged
from 0.22 mg L1 to 11.3 mg L1 and in bottled water from
0.01mg L1 to 12.2 mg L1. Urine B concentrations ranged from
0.45 mg L1 to 17.4 mg L1 with a median value of 4.28 mg L1.
A positive correlation was observed between urine B and tap
water B levels in the houses of the volunteers. The group
strongly recommended that water B levels be monitored in
Northern Chile and that regulatory standards be introduced to
limit exposure and protect public health.
5.4.7 Bromine. Human studies of drug metabolism and
elimination oen necessitate the use of a 14C radiolabelled
analogue of the drug for quantitative determination of drug
metabolites. To avoid this exposure risk, Meerman and
colleagues53 investigated the application of HPLC coupled withJ. Anal. At. Spectrom.both ICP-MS and ESI-MS to monitor the elimination of Br
species in faecal samples from subjects administered a
bromine-containing anti-tuberculosis drug (TMC207). Quanti-
tative determination of Br species was performed using on-line
ID-ICP-MS, whilst structural information on the Br species was
obtained using ESI-MS. The reported LOD for the drug was
1.5 mg L1 which was the same order of magnitude as that for
radio-detection methods. The authors concluded that the
analytical gures of merit supported the application of this
approach rather than one using a radioisotope.
5.4.8 Cadmium. Whereas past ASU clinical reviews have
always tended to focus on the toxicity of Cd to biological systems,
this review sees a completely different aspect of Cd determina-
tion being reported where Cd was used as an elemental tag to
quantitatively determine very low levels of total protein inhuman
urine.54 Determination of urinary proteins has conventionally
been performed using colorimetric assays. In this novel
approach, the researchersusedCdTequantumdotnanoparticles
to label urinary proteins for indirect quantitative determination
using ICP-MS. The workers considered CdTe nanoparticles to
have outstanding properties for such measurements, having
high sensitivity affordedby the large number of detectable atoms
within each nanoparticle tag. Urine proteins were directly
conjugated with the nanoparticles by incubation in wells of
micro-titer plates. Aer washing, the protein–nanoparticle
conjugate was dissolved in 5% HNO3 and diluted 15-fold in 1%
HNO3 for quantitative determination of Cd. An LOD of 0.008 mg
mL1 for human serum albumin was reported and a wide linear
range extending to four orders of magnitude. The method was
assessed by comparing results obtained for 50 urine samples
using the tagging method with those using a hospital reference
method based on colorimetric assay. Good agreement (r¼ 0.988)
was reported between the two methods.
5.4.9 Chromium. It is not oen that this review covers
incidents of acute metal poisoning. However, the case reported
by Goulle et al.114 merits comment because of its positive
outcome. Following accidental ingestion of a 30 g L1 K2Cr2O7
solution (estimated 3 g Cr ingested), the patient was admitted
into hospital intensive care where whole blood, plasma, urine
and hair Cr levels were monitored using ICP-MS. The patient
was monitored for 7 days aer which he was discharged from
intensive care with no evidence of renal or liver failure. Levels of
Cr in body uids and hair were monitored for a further 42 days.
Over this period, plasma Cr declined from a peak of 2088 mg L1
to 5 mg L1, blood Cr from 631 mg L1 to 129 mg L1 and hair Cr
from 3512 mg g1 to 10 mg g1. This individual clearly had very
effective metabolic processes for dealing with biologically active
CrVI and reactive oxygen species and the biotransformation of
CrVI to CrIII, which would have been worth investigating further.
5.4.10 Copper and zinc. With continuing developments in
analytical techniques and changes in environmental exposures
and dietary habits, it is pertinent to continue to review reference
intervals for essential trace elements in ‘vulnerable’populations. Lin
et al.25 reported reference intervals for Cu andZn in serum froma
healthy American paediatric population. Serum Cu and Zn were
determined using ICP-MS and statistical analyses performed
















































View Article Onlinedifference in Cu reference levels in different age groups but this
relationship was not observed with Zn. Age-dependent reference
intervals forCuwere 75–153mgdL1 for ages <10 years, 64–132mg
dL1 for ages 10 to 12.5 years and 57–129 mg dL1 for ages >12.5
years. The reference interval for Zn was 64–124 mg dL1.
An Australian research team115 presented work that implied a
role for labile Cu in the pathogenesis of Alzheimer's disease. The
researchers used ICP-MS to determine total concentrations of Cu
in post mortem cortical tissue from Alzheimer's disease patients
and non-dementia control subjects. The group also determined
the proportion of labile Cuusing aCu–phenanthroline assay and
the level of oxidative tissue damage bymeasuring the presence of
thiobarbituric acid-reactive compounds. It was observed that
both total Cu and labile Cu were elevated in the Alzheimer's
disease group and also noted that cortical tissue from this group
had a greater capacity to bind Cu2+. The hypothesis was pre-
sented that the observed changes reected a breakdown of Cu
homeostasis in Alzheimer's disease.
Becker et al.77 conducted a metallomic study of intracellular
Zn distribution and Zn-protein binding in slugs, which are
commonly used as a monitoring organism for environmental
contamination. Intracellular localisation of Zn was determined
using LA-ICP-MS. Protein binding of Zn was also determined
using LA-ICP-MS following one dimensional separation of
proteins by PAGE. The researchers observed that Zn was
detected in three prominent bands at 75, 100 and 150 kDa.
Efforts were made to identify the proteins usingMALDI-TOF-MS
analysis of tryptic digests but no matches with previously
characterised mollusc proteins were made.
A number of papers in this review period describe spectro-
metric methods to determine trace elements used as probes to
indirectly determine other biomolecules (see also Section on Cd).
In the method described by Zheng et al.,116 the measurement of
CuII using AAS was used to indirectly determine concentrations
of adrenaline in serum samples and pharmaceutical prepara-
tions. The method relied on the reduction of CuII to CuI by
adrenaline in the presence of SCN and the formation of a
CuSCN emulsion. Measurement of the residual CuII was used to
calculate the concentration of adrenaline in the sample. The
authors reported that the method could quantitatively deter-
mine adrenaline concentrations between 0.08 and 6 mg mL1. It
is open to question whether the specicity and sensitivity of
these indirect methods matches those of methods developed to
directly measure the biomolecule of interest.
5.4.11 Gold. Although gold-based drugs have been used
therapeutically for more than 40 years in the treatment of rheu-
matoid arthritis, little is still known about its mode of action.
Albert and colleagues52 described the development of methods
coupling LC with ESI-MS and ICP-MS to characterise and
quantitatively determine Au species generated by reaction
between the drug Auranon and glutathione or human serum
albumin. It was observed that Auranon undergoes ligand
exchange and the triethylphosphine-gold species covalently
binds to both biomolecules and proposed this as a potential
reaction pathway for the drug.
5.4.12 Iodine. Over the 25 years that the ASU review series
has been published, the advancements in instrumentation haveThis journal is ª The Royal Society of Chemistry 2013led to opportunities to develop methodologies to determine
elemental concentrations and distributions at the cellular and
intracellular level rather than the macroscopic organ and tissue
level. This is exemplied in the paper by Giesen and
colleagues90 who developed a method to determine I in bro-
blast cells and thin tissue sections using LA-ICP-MS. It was
observed that, following incubation of cells and tissue sections
in an I solution for 60 s, I was preferentially located in cell
nuclei. Spatial resolution was reported to be sufficient to detect
small cell nuclei in liver biopsy tissue sections. The group also
investigated the use of I as an internal standard to correct for
tissue inhomogeneity in the simultaneous determination of two
breast tumour markers (Her2 and CK7).
A comprehensive review of recent literature on methods to
determine I in environmental, biological and clinical matrices was
undertaken by Moreda-Pineiro and colleagues.15 The review
covered different sample pre-treatment methods to extract total
I as well as specic I species. It examined the most commonly
used techniques for the determination of total I and the
coupling of chromatographic and electrophoretic methods to
spectrophotometric instrumentation for I speciation.
5.4.13 Lead. Each review period always sees a signicant
number of papers reporting the determination of Pb in bone using
XRF. Yet, in contrast with the enormous amount of effort
expended in developing interlaboratory comparison and pro-
ciency testing schemes to improve the measurement of Pb in
blood, this review reports on the rst publication of work to
compare the performance of different laboratory systems
undertaking in vivo bone Pb measurements using XRF. Bellis
et al.20 circulated samples of 9 goat tibiae to 15 laboratories
performing bone Pb measurements with XRF instruments and
who had agreed to participate in the exercise. The bone samples
had mean Pb concentrations ranging between 1.8 mg g1 and
35.8 mg g1 Pb dw, as determined by a reference method using
ICP-MS. The intercomparison exercise revealed that 8 of the
laboratories showed no analytical bias for any of the samples
whilst the remaining 7 laboratories reported biases for between
one and six of the nine samples distributed. To investigate the
performance of a novel miniature XRF system for determining
Pb in bone, Fleming and colleagues66 constructed sets of bone
phantoms from plaster of Paris doped with varying concentra-
tions of Pb. Both round and square cross-sectional surfaces
were prepared and, to simulate the in vivo scenario of overlying
so tissue, the team placed thin resin lms between the
phantom and the XRF instrument. The reported LOD for a
circular cross-sectional phantom with a resin layer of 2.7 mm
was 43  7 mg g1.
Work is continuously being undertaken to identify valid
biomarkers of early Pb exposure as alternatives to blood Pb
determination. Shepherd et al.117 used the high spatial resolu-
tion capability of modern LA-ICP-MS instrumentation to
examine the concentration of Pb in circumpulpal dentine of
deciduous teeth in order to investigate the exposure of infants
to this toxic element. By combining the Pb measurements with
histological data and a true time line of dentine growth, the
authors argued that meaningful exposure histories could be
















































View Article Onlinesections of individual teeth, each Pb measurement representing
a time span of 42 days. They correctly highlighted the dangers of
translating these measurements into blood Pb estimations
without a reliable history of the tooth sample, and were
undertaking further work to validate the method as a blood Pb
biomarker.
5.4.14 Magnesium. Following the rapid advances in met-
allomics, researchers are continuing to look at combinations of
sensitive techniques to elucidate intracellular spatial distribution
of trace elements. Lagomarsino et al.95 combined the use of two
nanoprobe methods to investigate intracellular concentrations
of Mg. The concentration distribution of Mg was derived by
normalising the spatial distribution determined using XRF
microscopy to the cellular thickness determined using atomic
force microscopy. The authors argued that the marked differ-
ences between elemental distribution and the normalised
concentrationmaps indicated that the normalisation procedure
was essential to obtain reliable information regarding the
functional role of elements in whole cells.
5.4.15 Manganese. Many recently published methods for
the determination of trace elements in biological matrices
using ICP-MS have relied on collision cell technology to eliminate
interferences from polyatomic species. However this technology
may not be effective for every element of interest. Richardson
et al.48 examined the use of collision cell technology to overcome
interferences from FeH on the quantitative determination of
Mn in plasma and whole blood. It was established that the
interference from FeH on 55Mn was not eliminated by this
approach. However, the interference was successfully overcome
by modifying the geometry of the skimmer cones of the ICP-
mass spectrometer. With this modied geometry, Mn was
quantitatively determined in blood and plasma samples
following dilution of the samples with 0.005% Triton X-100,
0.2% propan-2-ol, 0.2% butan-1-ol and 1% HNO3 and addition
of Ga as an internal standard.
5.4.16 Mercury. Kutscher et al.79 used p-hydroxy-mercu-
ribenzoic acid to label ovalbumin for indirect quantitative
determination through the measurement of Hg using LA-ID-ICP-MS.
The protein was labelled with 199Hg-enriched pHMB and sub-
jected to PAGE for ablation analysis of the protein bands. No
loss of Hg label was noted during any of the sample preparation
steps. The researchers compared the data obtained using ID
with an external calibration method based on the derivatised
protein and considered the ID method to be more precise and
sensitive, with a reported LOD of 160 fmol protein. It was also
regarded that the ID method was more reliable where complex
protein separation protocols were used.
Guzman-Mar et al.118 described a novel method for Hg
speciation analysis based on multi-isocratic elution chroma-
tography coupled with CV-AFS. A multi-syringe conguration
was used to separate iHg, MeHg and EtHg using a RP C18
column and two phase chromatographic elution with 0.005%
mercaptoethanol in 240 mM CH3COONH4–C2H3N (99 : 1 v/v)
followed by 0.005% mercaptoethanol in 240 mM CH3COONH4–
C2H3N (90 : 10 v/v). Eluted Hg species were oxidised by UV
irradiation and Hg released by reaction with SnCl2 for deter-
mination using AFS. The reported LODs were 0.03 mg L1,J. Anal. At. Spectrom.0.11 mg L1 and 0.09 mg L1 for MeHg, iHg and EtHg, respec-
tively. The method was validated by analysing DORM-2 CRM. A
very novel sample preparation method was described by Yuan
et al.36 for the quantitative determination of Hg in human saliva
by AFS. Mercury was complexed with DDC and extracted into
ne droplets of 1-undecanol. The extract was then chilled on ice
to solidify the droplet into a single ball oating on top of the
solution. The ball was transferred to the CV-AF spectrometer for
determination of Hg. Concerns over the merits of salivary
measurements for monitoring exposures to toxic elements have
been previously highlighted and the applicability of this
method for clinical monitoring is questionable given the size of
the saliva sample required (25 mL !).
Monitoring occupational exposure to Hg is still extremely
important in areas where it is used in small scale gold mining
and extraction industries. Interest has previously been shown
on the development of portable analysers for eld measure-
ments of Hg in environmental and biological matrices. Baeuml
et al.119 investigated the use of two portable Hg analysers for
monitoring Hg in urine of subjects living in mining regions of
Zimbabwe, Tanzania and Indonesia. Urine samples collected
from volunteers were rstly analysed at the sampling site using
two different CV-AAS systems and then in a controlled labora-
tory environment using a conventional bench top Hg analyser.
The researchers recorded that values determined by the
portable systems were on average some 25% lower than those
determined by the stationary system, which may have been due
in part to the use of different reducing agents (SnCl2 for the
portable system and NaBH4 for the laboratory system). Even so
they argued that the mobile system has a useful role in
screening populations where environmental exposure to Hg is
an issue. It would appear that further work needs to be done on
developing methods for portable instruments that give consis-
tent results with laboratory-based systems.
5.4.17 Platinum. The focus for Pt continues to lie with its use
in anti-cancer treatment and the monitoring of drug adminis-
tration, intracellular distribution and elimination. Nguyen
et al.120 used CE-DRC-ICP-MS to separate and quantitatively
determine free oxaliplatin from liposome-entrapped drug in a
novel drug formulation. Interferences in the determination of
Pt were suppressed by using Ar as the collision cell gas. An LOD
of 29 ng mL1 was reported. The authors compared the results
for free and encapsulated Pt determined using this method with
those for total Pt following microwave digestion of the drug
formulation and found good agreement. They considered the
CE-ICP-MS method to be valuable for the in vitro character-
isation and quality assurance of liposome-based metallodrugs.
The Pt-based chemotherapeutic drugs exert their cytotoxic
action through formation of DNA adducts and work continues to
be undertaken on the identication and quantitative determi-
nation of these adducts in tumour cells and tissues. A research
group from Loughborough University reported two studies on
the determination of Pt–DNA adducts and subcellular local-
isation of Pt in human cancer cells. In the rst,76 the group
described a method for the sensitive determination of Pt–DNA
adducts in human carcinoma cell models using SF-ICP-MS.
















































View Article Onlineharvested and then either the DNA extracted or the cells frac-
tionated into four sub-cellular compartments. Samples were
digested for quantitative determination of Pt. Subcellular
distribution of Pt for cisplatin treated cells was 70% in cytosol,
17% in the membrane fraction, 9% in the nuclear fraction and
4% in the cytoskeleton fraction. In the second,75 the researchers
coupled HPLC with ESI-MS and SF-ICP-MS to study the in vitro
formation of Pt–DNA adducts following reaction of oxaliplatin
with mononucleotides, di-nucleotides and cellular DNA. With
optimised chromatographic conditions, ve Pt adducts were
formed in the reaction of oxaliplatin with mononucleotides and
three adducts in the reaction with di-nucleotides. The method
was also used to quantitatively determine oxaliplatin intra-
strand DNA adducts in human colorectal cancer cells. With a
reported LOD of 0.14 ppb Pt, the authors considered the
method suitably sensitive for assessment of adduct formation
in patients undergoing oxaliplatin chemotherapy. Unfortu-
nately, a serious side-effect of Pt-based drugs is their nephro-
toxicity. For this reason, Moreno-Gordaliza and colleagues89
studied the cellular deposition of Pt in kidney tissues of rats
administered pharmacological doses of cisplatin. Platinum was
quantitatively determined in 3 mm sagittal sections of kidney
using LA-ICP-MS and was found to accumulate in the cortex and
cortico-medullary region. The researchers also noted that Pt
accumulation was dramatically reduced when cilastatin was co-
administered with cisplatin, which they considered reected its
nephroprotective effect. The high analytical sensitivity (LOD ¼
50 fg) and excellent spatial resolution led them to conclude that
the method was very well suited for investigation of metal
interactions at the intracellular level.
5.4.18 Rare earth elements. Although papers on the deter-
mination of REEs regularly appear in this ASU Review series,
over the past 20 years there has never been a paper specically
describing the determination of Sm in clinical or biological
matrices until now. Concerns over the increasing use of REEs in
medical and industrial applications led Ahlem et al.97 to inves-
tigate the intracellular localisation of Sm in mammary tissue of
lactating Wistar rats following administration of the element.
The group used TEM and SIMS to reveal the presence of Sm-rich
deposits in the lysosomes of epithelial cells from the mammary
glands. No Sm-rich deposits were observed in the untreated
control group. It was concluded that lysosomes were the sites of
intracellular accumulation of foreign elements, including the
REEs and hypothesised that the Sm deposits were composed of
insoluble phosphates.
It was similar concerns over the exposure to the general pop-
ulation to Ce from the growing industrial use of Ce and use of
CeO2 nanoparticles as a diesel fuel additive that led Michalke
and colleagues121 to investigate whether there was an increased
risk of nutritional exposure for breast-fed babies due to transfer
of Ce from maternal blood into breast milk. The group devel-
oped a method for the quantitative determination of Ce in
serum and breast milk using ICP-MS. Breast milk samples from
subjects in Munich and Madrid had similar median Ce
concentrations of 13 ng L1, whereas serum Ce concentrations
were higher in the Madrid study group (21.6–70.3 ng L1)
compared with the Munich group (<10 ng L1). The researchersThis journal is ª The Royal Society of Chemistry 2013observed no enrichment of Ce in milk frommaternal blood and
concluded, therefore, that there was no increased exposure risk
for breast-fed babies.
The increasing use of Gd-based MRI contrast agents in medical
diagnoses has encouraged the development of simple and rapid
methods to determine Gd in blood and urine samples to
monitor the Gd dose administered and the kinetics of elimi-
nation in patients undergoing MRI. Telgmann et al.73 investi-
gated TXRF as an alternative to more conventional ICP-MS for
the quantitative determination of Gd in human body uids. The
method was evaluated by comparison with measurements
made using ICP-MS. Limits of detection of 100 mg L1 and 80 mg
L1 were reported for urine and plasma respectively and the
author considered the method to be an attractive alternative to
ICP-MS for clinical laboratories undertaking Gd measurements
in biological matrices. A second group from the University of
Trieste93 also described the use of SR-XRF at both the macro and
microscopic level to determine the hepato-biliary deposition of
a Gd-based MRI agent in ex vivo model systems.
Handley and colleagues122 considered many published
methods for the determination of La in biological samples to be
unsuitable for routine use due to complicated and aggressive
sample pre-treatments. For this reason they developed a simple
method for the determination of La in serum using ICP-MS. The
method was used to measure serum La concentrations in
patients administered La2(CO3)3 as a phosphate binder for stage
V chronic renal disease. The reported LOQ was 0.1 mg L1 and in
all samples analysed from subjects not receiving La2(CO3)3, the
concentration of La was below the LOQ. Even in subjects
receiving doses of 500–1500 mg per day only 12 samples out of
20 had quantiable concentrations of La. The results indicate
that there is no accumulation of La in patients administered the
agent but does suggest that some form of sample treatment is
required to improve analytical sensitivity for the analysis of this
element in biological matrices.
5.4.19 Rubidium. Since the publication in 1984 of research
suggesting Rb has anti-cancer activity through the raising of
intracellular pH, there has been little further work to substan-
tiate or refute the hypothesis. However, some interest appears to
have been reignited with the work described by Su et al.123 The
group investigated the relationship between urinary Rb
concentrations and incidence of breast cancer. Urine samples
were collected from 240 women with invasive breast cancer and
246 age-matched controls. Urine Rb was quantitatively deter-
mined using ICP-MS. The creatinine-correctedmedian, 25th and
95th percentile values were 2253, 16 068 and 3110.5 mg g1
creatinine for the cancer group compared with 2921.9, 2367.9
and 4142 mg g1 creatinine in the control group. Aer adjusting
for confounding risk factors the authors hypothesised that
urinary Rb was signicantly and inversely associated with breast
cancer risk and considered determination of urine Rb as a
potential biomarker for breast cancer risk. It will be interesting
to see if this recent publication stimulates further work to
establish any anti-cancer role for Rb in humans.
5.4.20 Selenium. The enormity of the challenge in trying to
interpret the biological signicance of the multitude of sele-
















































View Article Onlinewas brought home by the report of Preud'homme et al.50 who
presented a comprehensive cartography of Se metabolites syn-
thesised during the enrichment of yeast with SeIV. They repor-
ted the detection of 49 compounds using on-line SEC with both
ICP-MS and ESI-MS. Ballihaut and colleagues23 presented an
important systematic study to establish quantitative values for
the major selenoproteins, selenoprotein P, glutathione peroxi-
dase 3 and selenoalbumin in NIST SRM 1950 Metabolites in
Human Plasma. The researchers used a combination of on-line
ID affinity chromatography-ICP-MS, LA-ICP-MS and tandem
MS to identify and quantify the three Se containing species
and reported values of 50.2  4.3 ng g1, 23.6  1.3 ng g1
and 28.2  2.6 ng g1 as Se for selenoprotein P, glutathione
peroxidase 3 and selenoalbumin respectively. A study by Gam-
melgaard et al.124 also indicated that Se metabolism in humans
is a complex process. The group used LC-ICP-MS to investigate
the urinary excretion of Se species following sequential oral
administration of 82Se labelled selenate and selenite to seven
healthy volunteers. The volunteers were given a solution of
selenate containing 74.3 mg 82Se and urine samples collected
over the next 24 h. The same procedure was followed, aer a
four week gap, with administration of a solution of selenite
containing 74.4 mg 82Se. The authors reported that the mean
total urinary excretion of Se aer selenate administration was
33.7% compared with only 3.2% following selenite adminis-
tration. The researchers also noted that, in six of the volunteers,
the majority of the Se excreted following selenate administra-
tion was unchanged, whilst in one volunteer some 20% had
been converted to selenosugar. It may be concluded that sele-
nate and selenite are metabolised by different pathways.
Malinouski et al.94 used XRF tomap the cellular distribution of
Se in mouse liver and kidney. They observed that Se was
uniformly distributed in liver tissue whereas in kidney there
were both areas of uniform Se distribution but also localised
areas of high Se concentration. The main areas of localised high
Se were the proximal tubules. By studying the Se distribution in
mouse strains decient in either selenoprotein P or glutathione
peroxidase, they established that the proximal tubule localised
Se was associated with glutathione peroxidase.
5.4.21 Thallium. Thallium is used in various specialised
industries including optics and electronics, but has gained
particular historical notoriety through some high prole
deliberate poisonings. Because of its industrial and nefarious
uses, methods have continuously been developed to determine
concentrations of Ti in biological matrices in order to monitor
occupational exposure or assess accidental or deliberate intox-
ication. Solovyev and colleagues125 described a method for the
direct determination of Ti in whole blood using ETAAS with
high frequency modulation polarisation Zeeman background
correction. Sample preparation was a simple ve-fold dilution
with 0.1% Triton X-100. Matrix interferences were overcome by
using a rhodium treated L'vov platform and an NH4NO3–
Pd(NO)3 chemical modier. The method was assessed by ana-
lysing a human plasma SRM and spiked blood samples, and an
LOD of 0.2 mg L1 was reported.
5.4.22 Titanium. The continuing expression of concerns
over increasing serum concentrations of metal degradationJ. Anal. At. Spectrom.products from titanium based orthopaedic implants led the
research group of Sanz-Medel at Oviedo University27 to develop a
sampling strategy and analytical method for the quantitative
determination of total Ti in human serum using ID-ICP-MS in
order to establish the basal level of Ti in populations with and
without orthopaedic implants. By minimising sample handling
and pre-treatment, an LOD of 0.05 mg L1 was achieved, which
permitted the researchers to establish a mean Ti concentration
of 0.26 mg L1 in a control population (n ¼ 40). The authors
compared this background level with those found in groups of
patients with different Ti implants. Coupling anion-exchange
LC with double-focussing ICP-MS also enabled the group to
establish that 99% of serum Ti was bound to serum transferrin.
5.4.23 Uranium. Nigeria is a principal area for mining of
U. Hollriegl et al.,126 therefore, considered it important to
establish a baseline value for urine U in non-exposed Nigerian
populations in order to better assess cases of environmental
exposure frommining activity. They determined U in 24 h urine
samples collected from adult and child volunteers in a low
environmental U region of SW Nigeria. Urine U was determined
using ICP-MS and corrected for creatinine concentration. The
median and range determined in adults were 33.4 ng g1 and
2.52–252.7 ng g1, respectively. The median value was higher in
children under 15 years (76 ng g1). These values were consis-
tent with those determined for non-exposed populations in
other countries and the authors, therefore, considered them to
be appropriate as baseline values for the Nigerian population.
The work of Muikku and Heikkinen127 re-emphasised the
importance of using the correct biological matrix for monitoring
human exposure to toxic elements. The researchers investigated
the perennial debate of distinguishing external contamination
from internal element incorporation in human scalp hair by
examining the exogenous binding of U to hair from uranium-
rich household water. Aer incubating hair samples in the
uranium-rich water, the samples were washed using two
commonly used washing procedures and residual U determined
using ICP-MS. The authors noted that, even aer washing with
well established procedures, hair U concentrations were still
three orders of magnitude above the levels determined before
incubation with uranium-rich water. As has been stressed in
this review before, they concluded that great care needs to be
taken when using hair as a biomarker of the internal dose of
exposure.6 Applications: drugs and pharmaceuticals,
traditional medicines and supplements
A comparison of TXRF with other techniques for the measure-
ment of residual metals in active pharmaceutical ingredients,
by Antosz et al.74 was discussed in Section 4.5.2. While this
application may develop in importance in the future, for the
moment other techniques are more usually employed to analyse
therapeutic agents. Concentrations of adrenaline in pharma-
ceuticals and also in serum samples were determined using AAS
by Zheng et al.116 This was achieved by exploiting the reaction
between a known amount of Cu2+ and adrenaline in the pres-
















































View Article Onlineformation of CuSCN as a white emulsion which is then
removed. Measurement of the residual Cu2+ provided an indi-
rect determination of the concentration of the adrenaline.
Delivery of drugs to the site where they exert their effective
action, without causing side effects, is the ideal therapeutic
treatment. However, this is not easily achieved. One approach
that has attracted a lot of interest, particularly for anti-cancer
drugs, is to encapsulate the agent within phospholipid particles
known as liposomes. A liposomal-oxaliplatin formulation was
investigated by Nguyen et al.120 to assess how much free oxali-
platin remained in prepared material. Capillary electrophoresis
coupled to ICP-MS was used to separate the free drug from that
within the liposomes and for the simultaneous measurement of
P and Pt. Good agreement was shown between the concentra-
tions of Pt in the two fractions and the total Pt measured
following digestion of the original formulation. The authors
recommended this technique for quality assurance when
preparing liposomal-based formulations of metallodrugs.
Concern over the level of As in sh oil supplements such as
cod liver oil and capelin oil led Ruiz-Chancho et al.128 to develop
a method to screen preparations for arsenolipids by RP-HPLC-
ICP-MS. Two techniques to reduce the inuence of carbon on
the As response were investigated; addition of CH3OH, either
via a post-column T-piece or directly into the spray chamber. A
more constant response for different arsenolipids was better
achieved with the post-column device. Examination of sh oil
samples identied As-containing fatty acids, hydrocarbons and
an unknown group of compounds of lower polarity.
The British Museum has a number of bronze containers from the
Roman period which contain residues believed to be medicinal
preparations including ‘Punic wax’, as described by Pliny.
Analysis of seven samples by GC-MS, XRF and Raman spec-
troscopy was reported by Stacey.129 Beeswax, fat, conifer resin,
gum-derived sugars, Pb and Zn salts were identied. Likely
applications of the medicines were discussed by the author.7 Applications: foods and beverages
7.1 Progress for individual elements
7.1.1 Arsenic. A CF method to determine the bio-
accessibility of iAs and organic As species in seafood was devised
by Leufroy et al.46 Powdered sample, packed into amini-column,
was leached successively with articial saliva, then gastric and
intestinal juices with the effluent owing directly into the ICP-
mass spectrometer nebuliser. Digestion of the remaining
residue conrmed the mass balance of the system. Non-toxic
forms were easily released using the uids studied but iAs was
poorly bioaccessible. Use of hybrid (HY) and strong anion
exchange resins (SAX) was tailored to enable in-line determina-
tion of As species in water.130 The SAX at pH < 8.0 does not retain
AsIII while a HY-hydrated FexOy resin does not retain DMA
V,
allowing direct determination of these species in the effluent.
The HY-AgCl resin retained all iAs allowing the effluent to be
used to assess organic As. When coupled to an ICP-mass spec-
trometer, the LOD was 0.2 mg L1 with RSDs between 3.5 and
5.1%. Another extraction method for As species in rice, wheat
and sh, was reported by Raber et al.131 based on a triuoroThis journal is ª The Royal Society of Chemistry 2013aceticacid–H2O2 sample extraction. Subsequently, As
V was
determined by AEC-HPLC-ICP-MS with aqueous malonic acid
(5–10mM at pH 5.6) as mobile phase. Peaks were sharp and well
resolved and AsV eluted with a retention time of just 5 min.
7.1.2 Mercury. Newly synthesized magnetite nanoparticles
were used for a rapid extraction and preconcentration of iHg at
sub-ppb concentrations from water and sh samples.39 The
magnetite nanoparticles, functionalised with 1-(p-acetylphenyl)-
3-(o-ethoxyphenyl)triazene iHg-binding ligands, can be isolated
from the sample with a magnetic eld. When coupled with ICP-
AES, this extraction and system can deliver a preconcentration
factor of 500 with an LOD of 0.04 ng mL1 and an RSD of 2.09%.
The iHg sorption capacity was 10.26 mg g1 at pH 7. A sample
preparation scheme involving both an ultrasonic probe at
20 kHz and an ultrasonic bath at 40 kHz was shown to be 40%
better than either technique used in isolation.35 In addition,
L-cysteine was used to weaken the Hg–C bond for better
extraction of MeHg. The total extraction time was only 60 s and
LODs for iHg and total Hg were 0.0086 and 0.0072 mg L1, with
RSDs of 2.4% and 3.1%, respectively.
7.1.3 Selenium. A non-chromatographic on-line DLLME
method to effectively preconcentrate and separate Se species with
an ionic liquid (IL) system for determination by ETAAS was
devised by Martinis et al.38 The IL was tetradecyl(trihexyl)phos-
phonium chloride (CYPHOS IL 101) and this was used to
separate the SeIV–APDC complex formed; SeVI was indirectly
determined by prior reduction. The LOD was 15 ng L1 and the
RSD was 5.1% (at 0.5 mg L1). High Mr Se species in enriched
soybean, although previously observed but uncharacterised,
was identied by Chan and Caruso132 as a Se-containing
peptide, part of the Bowman-Kirk protease inhibitor sequence.
A comprehensive metallomic identication of Se metabolites in
enriched yeast was undertaken by Preud'homme et al.50 The use
of UPLC with optimised fractionation improved the identica-
tion of minor Se-containing amino acids and oligopeptides.
7.1.4 Other elements. Some of the novel applications
involving measurements of other elements are given here while
Table 2 includes references to other work. Determination of Al
in Chinese processed food samples (187 samples purchased in
Shenzhen) led to the realisation that high levels (up to 1126 mg
kg1) were due to the additives used, and not the raw food,
which presented with Al concentrations from 0.1 to 451.5 mg
kg1.133 Interferences in the determination of Cd by ID-ICP-MS
have been overcome by Zhu and Chiba41 using two chelating
columns. Nobias Chelate PB-1 and, more effectively, InertSep
ME-1 were used to remove nearly 100% Mo, Sn and Zr from
samples at pH 7. Comparison of I speciation and bioavailability
between iodized salt and chicken eggs was carried out by Lipiec
et al.134 A two-stage simulated digestion (pepsin followed by
pancreatin) of both egg yolk and albumin was devised and I
determined by SEC-ICP-MS. Yolk contained 37-times more I
than the white while the bioavailability from the former was
10% and from the white it was 33%; this is in contrast to 100%
availability of I in kitchen salt. However, the bioavailability
from egg yolk decreased with cooking indicating I remains
bound to non-digestible, coagulated and insoluble proteins.
Several other analytical methods for the determination of I wereJ. Anal. At. Spectrom.




presentation Sample treatment/comments Ref.
Al Wheat our AA; ETA; L Samples were digested in a mixture of HNO3 and H2O2 in closed PTFE
vessels. A Mg(NO3)2 solution 1 g L
1 was used as the matrix modier.
The RSDs obtained ranged from 1.7% to 2.4%, and recoveries were
reported in the range 98 to 102%
33
Al Food and food
additives
MS; ICP; L A survey of the Al content of processed foods, raw material and food
additives in China (178 samples). High levels of Al were reported for
some processed foods (up to 1226 mg kg1) and food additives





AA; FI-HG; L; Contaminated foodstuffs and groundwater were collected and analysed
using a FI-HG method to estimate total As content. The As levels in boro





MS; ICP; L MS;
ICP; HPLC
Gluten-free rice, cereals with gluten, and pure´ed baby foods from Spain,
UK, China and the USA were analysed for total and iAs, the latter using
prior chromatographic separation. It was reported that all rice-based
products contained high levels of iAs with values greater than 60% of the
total As content
149
As Rice and infant
cereal products
MS; ICP; HPLC Extraction of the As species (iAs, MMA, and DMA) was performed using
0.2% HNO3 and 1% H2O2. Results for the analysis of 29 samples were
reported and total As found was in the range 1 to 324 mg kg1. The CRMs





MS; ICP; IC Method for determination of total As and As species using IC separation
prior to detection. Samples were found to contain iAs and DMA
148
As Rice wheat and
tuna sh
MS; ICP; HPLC Samples were extracted with triuoroacetic acid–H2O2 and arsenate
separated by anion-exchange HPLC using 10 mM malonic acid at
pH 5.6 as mobile phase prior to detection. The LOD was reported as
0.05 mg As L1 (for 20 mL injection) or1 mg As kg1 in dry sample
131
As Seafood MS; ICP; HPLC Total As content, in seafood samples and dialyzable and non-dialyzable
fractions, was determined aer a microwave-assisted acid digestion
treatment. As species were determined following an optimised matrix
solid phase dispersion and separation by HPLC. The accuracy of the
procedure was assessed for total As using DORM-2 and BCR-627 CRMs
152
As Seafood MS; ICP; L Continuous-ow on-line digestion by pumping articial saliva, gastric
and intestinal juices through a mini-column of powdered sample; the
leachates were supplied to the ICP directly for determination of bio-
available total As and via an anion exchange column for detection
of As species
46
As Fish oils (cod liver
oil and capelin oil)
MS; ICP; L A method for screening lipid-soluble As compounds in sh oils by
RP-HPLC using a gradient elution with CH3CH2OH and CH3COO

buffer at pH 6. The addition of MeOH post-column through a T-piece
maintained constant response for several As-containing lipids covering a
wide range of polarities. Reported LODs were in the range 5–11 mg As L1
128
As Drinking water MS; ICP; L,
AA; HG; L
Evaluation of strong base anion exchange and hybrid resins for the
separation and subsequent determination of iAs and organic As species.
The LOD for the ICP-MS method was given as 0.2 mg L1 and the RSD of
all As species investigated was reported in the range 3.5 to 5.1%
130
B Drinking water AE; ICP; L The level of B in Chilean public tap water was determined directly
and reported in the range 0.22 to 11.3 mg L1, with a median value
of 2.9 mg L1. The concentrations of B found in bottled water
samples were in the range 0.01 to 12.2 mg L1 The levels of
B reported were higher than WHO recommended limits
113
Bi Water AA; F; L Ion-pair dispersive LLME was used to preconcentrate Bi by injecting
2-(5-bromo-2-pyridylazo)-5-(diethyl amino) phenol reagent as
complexing agent and 700 mL of (CH3)2CO (dispersing solvent)
containing 75 mL of dichlorobenzene (extracting solvent) into 10 mL of
aqueous solution. An enrichment factor of 28.6 was achieved. An LOD of
3.0 ng mL1 was reported and the RSD for the method was given as1.5%
111





















































presentation Sample treatment/comments Ref.
Cd Food MS; ICP; L A sample pre-treatment method was developed to eliminate spectral
interferences. An aliquot of 0.6 mL of NH4OHwas added to 10 mL of pre-
digested sample (in 0.3 M HNO3) which was then loaded into a syringe-
driven SPE chelating column at a ow rate of 5 mL min1. The column
was washed with H2O prior to elution of Cd with 2 mL of 0.3 MHNO3. An
ID-based procedure was used for analysis and was validated using NMIJ
CRMs
41
Cr Black, green and
herbal teas
AA; ETA; L Samples soaked in boiled H2O (200 mL) were treated with 0.1 M Na2CO3
to measure total CrVI and microwave acid digestion was used to prepare
samples for total Cr determination. Total CrVI was reported in the range
0.03 and 3.15 mg g1 for black tea and between 0.03 and 0.14 mg g1 for




AA; ETA; Sl Samples were prepared as slurries and 10 mg Nb was added as permanent
modier. The LOD for the method was given as 86.6 ng g1 for a 0.75%
(w/v) slurry concentration. The RSDs were reported to be <10%.
Recoveries for Cr in CRMs were in the range 95 to 103%
182
Cr Drinking water AA; F; L Speciation by adsorption of CrVI oxyanions on a Ni–Al layered double
hydroxide nano-sorbent at pH 6.0. The determination of total Cr, and
indirectly CrIII, was subsequently achieved by pre-oxidation of CrIII to
CrVI using H2O2. The LOD for Cr





Tea samples were prepared using acid digestion, alkaline solubilization
and conventional aqueous infusion. The determination of F as CaF was
achieved by molecular absorption spectrometry. The LOD was reported
as 0.16 mg L1. The concentration of F found in the 10 solid samples
analysed ranged from 42 mg g1 to 87 mg g1
61
Fe Baby food AA; F; Sl Samples were dried overnight at 105 C and ground in an agate mortar. A
500 mg sub sample was slurried in 20 mL of 0.05% Triton X-114
containing 0.1 M HNO3 and homogenised for 5 min before direct
analysis of the suspension. The reported LODwas 5.5 mg g1 and the bias





AF; CV; L The iHg and total Hg in sh samples were completely extracted
ultrasonically in 60 s. L-Cysteine was used to weaken the Me–Hg bond.
LODs for iHg and total Hg in aqueous solutions were 0.0086 mg L1 and
0.0072 mg L1, respectively. The RSDs for 11 replicate determinations of
1 mg L1 Hg were 2.4% for inorganic Hg and 3.1% for total Hg. The
accuracy of the method was veried using CRMs
35
Hg Seafood MS; ICP; L,
MS; EI; L
A review of species specic ID and species non-specic ID methods for
the determination of Hg species in seafood
14






AA; ETA; S Direct solid samplingmethod for total Hg used Ir lm and 5 mg Pd + 3 mg
Mg solution as permanent and co-injected chemical modiers. For
direct chemical speciation (Hg2+ and MeHg by difference from
total Hg), 5 mg Pd + 3 mg Mg + 0.5% w/v Triton X-100 co-injected
modiers were employed. Three CRMs were used to verify the




AF; CV; L Chromatographic speciation of iHg, MeHg and EtHg on an RP C18
monolithic column using a multi-isocratic elution with 0.005% 2-
mercapthoethanol in 240 mM NH4CH3COO (pH 6)–CH3CN (99 : 1, v/v),
followed by 0.005% 2-mercapthoethanol in 240 mM NH4CH3COO (pH
6)–CH3CN (90 : 10, v/v). The eluted Hg species were oxidized under post-
column UV radiation and reduced using SnCl2 in an acidic medium
prior to detection
118
Hg Water and Fish AE; ICP; L Modied Fe3O4 magnetite nanoparticles functionalized with triazene
groups were used to extract and preconcentrate Hg from water and sh
samples using an externally applied magnetic eld. It was reported that
the LOD for the method was 0.04 ng mL1 and the RSD was 2.09% for







Hg species were derivatised for GC using a 1% (m/v) NaBPh4 solution,
followed by extraction of Hg species for analysis. Recoveries were
reported in the range 99% to 104% for HgII andMeHg. The LODs for HgII
and MeHg were 0.77 and 0.80 mg L1, respectively
65





















































presentation Sample treatment/comments Ref.
I Foods and dietary
supplements
MS; ICP; L Samples were digested in KOH in an oven or openmicrowave vessel. The
LOQ reported for the method was 25–50 mg kg1. The RSDs were on
average 2.3% for the analysis of a milk powder RM and 4.3% for the
analysis of a dietary supplement tablet RM. Results were reported as
100% and 94.2% of certied values respectively
135
I Foods and diets MS; ICP; L Samples were prepared using TMAH alkaline digestion. The accuracy
of the method was assessed by the analysis of NIST SRM 1549 non
fat milk. It was reported that the I content in foodstuffs analysed
using the method ranged from <0.02 to 0.101 mg kg1 for cereals,
87 to 299 mg kg1 for milk, and 86 to 271 mg kg1 for cheese products
136
I Infant formula and
adult nutritional
products
MS; ICP: L All samples were treated with HNO3 using closed vessel microwave
digestion and NH4OH solution was then added to the samples to prevent
loss of I.The LOD reported for the method was 0.3 ng mL1 as total I.
Results were obtained within certied limits for two NIST SRMs using
the method
137
I Milk MS; ICP; L 135 samples of cow's milk were analysed aer digestion with TMAH. It
was noted that there were no signicant changes to I content of cow's
milk over a 5 year period. A mean level of 122.0  36.8 mg L1 I was
reported in the samples
145
I Chicken eggs MS; ICP; SEC Egg samples were treated with buffer (Tris HCl, pH¼ 7.5) and enzymatic
extraction media in a two-stage digestion model simulating gastric
(pepsin digestion) and intestinal (pancreatin digestion) juices, to assess
in vitro bioavailability of I species
134
Li Mineral water XRF; —; L Li was precipitated with iron to yield a stoichiometric potassium lithium
periodatoferrate complex which was dissolved and pipetted onto Mylar
foil for XRF analysis. It was reported that Li could be determined at levels
as low as 1 mg using the method
72
Mn Drinking water AA; F; L See Cr, ref. 80. The determination of total Mn, and indirectly MnII, was
subsequently achieved by pre-oxidation of MnII to MnVIIusing KIO4. The
LOD for MnVII was reported as 0.47 ng mL1
80
P Fish diets AA; ETA; L Dry samples (100 mg minimum) were acid digested in a domestic
microwave system using Parr Teon bombs at high pressure.
A 1000 mg mL1 La solution was used as chemical modier in




MS; ICP; HPLC Soluble Se compounds were extracted from parts of cabbage with
protease XIV. Se species were separated in the enzymatic extracts
using ion exchange HPLC. The total Se found in cabbage leaves




MS; ICP; HPLC Multi-technique characterisation (including HPLC-ICP-MS and
HPLC-Chip-ESI-ion trap-MS) of Se-containing proteins in soybeans
132
Se Garlic AA; ETA; L An on-line ionic liquid dispersive micro-extraction system was used to
selectively separate SeIV by forming a Se–APDC complex followed by
extraction with CYPHOS IL 101. An LOD of 15 ng L1 was reported with
an RSD for 10 replicate measurements of 5.1% for 0.5 mg L1 Se
38
Se Turkey meat ICP; MS:L ICP;
MS:HPLC
In a study of the effect of diet supplements containing additions
of Se-enriched yeast or Na2SeO3, the tissues of female turkeys on




AA; ETA; L A ternary complex formed between V, 2-(20-thiazolylazo)-p-cresol, and
ascorbic acid, was subsequently extracted using Triton X-100, for
preconcentration of V. The LOD was reported as 0.05 ng mL1 V and the
RSD for the method was given as 3.9%
138
Zn Baby food AA; F;S See Fe, ref. 183. The reported LOD for Zn was 3.4 mg g1 183
Various (4) Second French
Total Diet Study
AA; F; L Foodstuffs (1319 types) that comprise the French total diet were analysed
for Ca, K, Mg and Na. Samples were prepared using microwave-assisted
digestion and introduced to the ame via a micro-sampling procedure.
Results were compared with those from the First French Total Diet Study
141
Various (9) Second French
Total Diet Study
MS; ICP; L Samples (1319) originating from the French Total Diet Study were
subjected to microwave-assisted digestion and analysed for Ag, Ba, Fe,
Ga, Ge, Sn, Sr, Te and V. The food groups containing the highest levels
for these elements were reported
142





















































presentation Sample treatment/comments Ref.
Various (9) Second French
Total Diet Study
MS; ICP; L Samples were prepared using microwave-assisted digestion prior to
determination of Co, Cr, Cu, Li, Mn, Mo, Ni, Se and Zn. The food
products containing some of the highest levels of these essential
elements included tofu, sh and shellsh, confectionery and ice cream
140
Various (7) Foodstuffs MS; ICP; L Optimisation of collision cell conditions to remove spectral
interferences for determination of trace elements (As, Cr, Co, Fe, Ni, Se
and V) in foods
47
Various (19) Infant formula MS; ICP; L Samples were digested in HNO3 using a microwave-assisted procedure
and CH3COOH was added to sample solutions and to standards prior to
the determination of 19 elements. Recoveries were reported in the range
95–108% and RSDs for the method were between 0.3 and 4.2%. Good
agreement with NIST SRM values was obtained
184
Various (3) Infant formula and
adult nutritional
products
MS; ICP; L Samples were digested using a closed vessel microwave oven system
incorporating internal standards (Ni and Te). The LOQs for Cr, Mo and
Se were reported as 0.4, 0.2, and 0.4 ng mL1, respectively. The accuracy
of the method was assessed using NIST SRMs
185
Various (10) Milk AA; ETA; L A W permanent modier with co-injection of Pd(NO3)2 and W-Ru
permanent modiers was used for the simultaneous direct
determination of As, Bi, Co, Cr, Cu, Fe, Mn, Pb, Sb, and Se in milk. An
air-assisted pyrolysis step was used to remove organic matter. Results for
the analysis of 14 commercial milk samples were reported
186
Various (4) Milk powder AE; ICP; L and
LA LIBS
Laser sampling techniques for the direct determination of Ca, Mg, Na
and Zn were compared. Accuracy was reported to be affected by matrix
effects and bias in the range 1–60% was reported for the methods
64
Various (20) Soy and dairy
yoghurts
MS; ICP; L Samples were microwave digested prior to analysis. Both Cu and Mn
were found at elevated levels (up to 30 fold) in soybean products in
comparison with dairy yoghurts and Ni at concentrations up to
450 ng g1 in some samples
146
Various (10) Dairy products
and meat
MS; ICP; L Mineral (Ca, K, Mg, Na, and P) and trace element (Cu, Fe, Hg, Se and Zn)
levels were measured in Icelandic whole milk, fresh cheese (skyr), rm
cheese (Gouda), lamb meat and minced beef, skimmed milk, cream and
whey. Seasonal and geographical variation of Se in milk was reported.
The Se content in meat was also found to be variable; Hg was reported as
below the LOD of 0.3 mg per 100 g except for one sample of cheese
139
Various (4) Fresh and
Processed Meat
AA; F; L AA;
ETA; L
Samples were treated with TMAH prior to determination of Ca, Cu, Fe
and Mg. The LODs reported were 45, 0.2, 16 and 0.3 mg g1, respectively
156
Various Green tea Various Certication and reference values were reported for three new issue NIST
green tea-containing reference materials; SRM 3254 Camellia sinensis
(green tea) leaves, SRM 3255 Camellia sinensis (green tea) extract and
SRM 3256 green tea-containing solid oral dosage form
22
Various (37) Tea leaves (NMIJ
CRM 7505a)
MS; ICP; L,
AE; ICP; L, AA;
ETA; L, AA; F; L
In the characterisation of an NMIJ developed CRM for trace element
content, property values were reported for 19 elements and informative
values for 18 elements including all of the lanthanides, except for Pm
21
Various (18) Vegetables (tomato,
cabbage, pepper,
and parsnip)
PIXE; —; L Samples were chemically mineralised and the resulting solution
deposited onto Mylar foil targets with Y added as internal standard. The
method was applied to the determination of 18 elements in SRMs
151
Various (6) Tomato paste MS; ICP; L The method was validated using NIST SRM 1573a (tomato leaves) with
relative errors reported in the range 1.4% to 9.0%. Tomato paste samples
gathered from the supermarkets in Turkey were analysed using the
validated method for Cd, Cu, Fe, Pb, Sn and Zn and results were
compared with literature values
187









Evaluation of a dual nebulisation system for the simultaneous
determination of hydride forming and non-hydride forming elements.
The LODs were reported in the range 0.002 to 0.0026 mg mL1 for the
hydride forming elements and between 0.0034 and 0.0121 mg mL1 for
the non-hydride forming elements; elemental recoveries were in the
range 97 to 103%
63





















































presentation Sample treatment/comments Ref.
Various Fish (tilapia tissues) MS; ICP; L Evaluation of experimental design applied to method development for
microwave-assisted digestion of samples (in 2.5 mL HNO3, 0.5 mL HCl
and 7.0 mL H2O) for multielement determinations. Agreement was
obtained with certied values for the analysis of DORM-3, DOLT-4 and
ECM-CE278 RMs
32
Various (18) Wheat our MS; ICP; L The method was applied to commercially available conventional and
organic wheat our samples
147
Various (20) Bread MS; ICP; L Concentrations of 20 minor, trace and ultra trace elements relevant to
human health were determined in three varieties of Lebanese bread
sampled at ve geographical locations
188
Various (14) Red wine MS; ICP; L Ultrasound sample preparation was used prior to determination
of lanthanides using FI. LODs were reported in the range
0.24 to 10.8 ng L1
45
Various (56) Red wine MS; ICP; L,
AE; ICP; L
A total of 56 elements were determined in 1397 samples of Australian
wine. The use of element composition to discriminate between wines

















































View Article Onlineproposed by Sullivan and Zywicki,135 Tinggi et al.136 and Pac-
quette et al.137 Preconcentration of V from tea, tomatoes and
wine by CPE was optimised using 2-(20-thiazolylazo)-p-cresol
and ascorbic acid to form the ternary complex.1387.2 Single and multielement applications in food and
beverages
7.2.1 Dietary intake studies. The never-ending issues of As
contamination in regions of the Indian subcontinent continue
to motivate research in understanding dietary intakes of toxic
elements. Samal et al.107 investigated As in drinking water and
foodstuffs in the Nadia region of West Bengal using FI-HG-
AAS. Total intake from foodstuffs, represented by boro and
aman rice (mean As content 780 and 674 mg kg1, respec-
tively), was calculated at 560 mg per day (adults) and 393 mg
per day (children) with 50–60% retention observed via urine
analysis. The I nutritional status in young children from
Australia was assessed by Tinggi et al.,136 analysing food by
alkaline TMAH digestion followed by ICP-MS. The mean daily
intake was very variable at 93.1  76.7 mg per day (range: 36.9–
288.1 mg per day). The Icelandic diet was studied by Reykdal
et al.139 for seasonal and geographical variations in 10 selected
mineral and trace elements using ICP-MS. Variations in Se
concentrations were only found in whole milk whilst
concentrations in beef were deemed to be variable and low
(1.4–9.6 mg 100 g1 w/w). Results from the 2nd French Total
Diet Study continue to be reported episodically by Guerin's
team.140–142 The food groups with the highest levels (‘sweet-
eners, honey and confectionery’ and ‘sh products’) were the
same as those reported last year.
7.2.2 Human milk and infant formula. The nutritional
suitability of human milk produced by mothers of preterm
infants in terms of Cu, Mn, Se and Zn was studied where
infants were born <34 weeks or with a body weight <1.8 kg.143
Although Mn exceeded daily requirements suggested by theJ. Anal. At. Spectrom.American Academy of Paediatrics and Cu was below, both
concentrations increased the closer the birth was to term.
Concentrations of Se and Zn met daily requirements regardless
of length of the pre-term period. Measurements were by AAS.
Exposure to Ce through industrial products or nuclear ssion
was thought to be of concern, motivating a biomonitoring
programme with paired samples of milk and serum from
Munich (Germany) and Madrid (Spain), using ICP-MS.121 The
median concentration of Ce in human milk was 13 ng L1 across
both regions, however blood serum concentrations were
around the LOQ of 10 ng L1 in Munich and, in Madrid, it
ranged from 21.6 to 70.3 ng L1. These data suggest there is no
increased risk to nursing neonates since no trans-mammary
enrichment was observed. The association between lifestyle
and heavy metal content (Cd, Hg, Pb) in humanmilk, measured
by AAS, was explored by Garcia-Esquinas et al.144 in samples
collected three weeks postpartum from mothers in Madrid
(Spain). Unsurprisingly, smoking and exposure to motor
vehicle traffic were shown to increase levels in Cd and Pb,
respectively (geometric means: 1.31 mg L1 and 15.56 mg L1).
Older women and those previously having given birth pre-
sented lower concentrations of Hg (general geometric mean:
0.53 mg L1) which the authors ascribe to a clearance mecha-
nism over a person's lifetime.
7.2.3 Milk and dairy products. The I status of cow's milk in
Thuringia (Germany) was monitored over a period of 5 years
(2007–2011) and compared with that of human milk from
mothers living in the same region.145 Samples were digested
with TMAH and I determined by ICP-MS. The mean I concen-
tration over the ve years was 122.0  36.8 mg L1 with organ-
ically produced milk containing on average 51 mg L1 less I
(P < 0.001). Human milk showed a slightly higher I concentra-
tion of 170  96 mg L1 but with larger variation among indi-
viduals. Dairy and soy yogurts were compared for micro-
nutrient value and toxic element status aer development of a
















































View Article Onlineto contain much higher levels of Cu and Mn (up to 30-fold
higher) while Ni was also higher in soy yogurt with maximum
concentrations recorded at 450 ng g1.
7.2.4 Cereals, our and rice. As constituents of staple diets
the trace element and mineral contents of cereals, our and rice
are particularly important. A comparison of organically and
conventionally produced wheat ours was undertaken using
an optimised and validated multi-element ICP-MS method.147
Signicant differences between the two agricultural practices
were found with concentrations of Cr, Mg, Mo, Ni and V being
higher in organic samples while those of conventional wheat
our were higher in Al, As, Cd and Pb. Organic brown rice
syrup (OBRS) can be used as a substitute for high fructose
corn syrup, as a sweetener for food products. As rice may
contain unreasonable levels of iAs it was suggested by Jackson
et al.148 that OBRS and nished foodstuffs could contain
inappropriate concentrations of As. Samples of toddler milk
formulae, cereal bars and high-energy foods were analysed by
ICP-MS and IC-ICP-MS and all contained higher As concen-
trations than were seen in products that did not include
OBRS. Most of the As was present as iAs with some MMA.
Organic milk formulae had up to six times more total As than
the US EPA safe drinking water limit. Total As and iAs
determination in infant rice from China, Spain, UK and USA
was undertaken using ICP-MS and HPLC-ICP-MS;149 gluten-
based cereals and pure´ed baby foods from Spain were also
analysed. The iAs content of rice samples was signicantly
higher than gluten-containing cereal and represented over
60% of total As with the balance being DMA. The Chinese
limit of 150 mg kg1 was not exceeded by 77% of samples
although when expressed as body weight of infants aged 8–12
months, iAs was higher than the predicted adult exposure
from drinking water.
7.2.5 Vegetables, fruits and nuts. The binding of Cd to
vegetable proteins was studied in Cd-exposed spinach using LA-
ICP-MS aer protein separation by PAGE and electroblotting
onto membranes.78 The Cd-bound protein was investigated by
FT-ICR and identied as ribulose-1,5-bisphosphate carboxylase/
oxygenase (RUBISCO). The authors then went on to prove
RUBISCO binds to Cd as well as to CuII, FeII and MnII.
The spatial distributionof Se species inwhite and red cabbage
that had been sprayed twice with solutions containing SeVI at
concentrations of 20 mg L1 and 0.5 mg L1, respectively, was
determined byMechora et al.150usingHPLC-ICP-MS. The total Se
concentrations, the soluble concentrations and the percentages
of the latter present as SeMet, were measured in root, stem and
leaves. For white cabbage, SeMet represented 94% of the soluble
Se from the roots (55% for red cabbage) while only 23% was
found in the soluble Se from leaves and stems. This was in
contrast to red cabbage where SeMet was 80% and 41% of the
soluble Se for leaves and stems, respectively.
Analysis by PIXE of four types of vegetable grown in
Romania was carried out by Pantelica et al.151 Samples were
digested and thin targets prepared by pipetting solutions onto
Mylar foils. This allowed determination of elemental concen-
trations (Al, As, Br, Ca, Cl, Cr, Cu, Fe, K, Mn, Ni, Pb, Rb, S, Se,
Sr, Ti and Zn) without corrections for X-ray self-absorptionThis journal is ª The Royal Society of Chemistry 2013and proton stopping in target, necessary when using thick
target preparation.
7.2.6 Fish and seafood. In vitro simulated gastric and
intestinal digestion/dialysis has again been used by Bermejo-
Barrera152 to assess the bioavailability of various As species
(AsIII, AsV, AB, AC, DMA and MMA) in raw seafood using ICP-MS
andmatrix solid phase dispersion. Dialysability was found to be
high (84.6–10%) for total As and species. Bioavailability was
negatively correlated with fat content although no correlation
was observed with protein content. Two simple and fast ETAAS
methods were proposed for the analysis of sh: one, for the
optimised and validated determination of total Hg, iHg and
MeHg in sh by Naozuka and Nomura,153 the other for the
determination of P with minimal sample amounts (100 mg dw)
as an alternative to colorimetric methods.59 Solid sampling
ETAAS with a mixed Pd–Mg chemical modier (5 mg Pd + 3 mg
Mg) was used for Hg speciation while an Ir lm was used in
addition for total Hg. Aer microwave-assisted acid digestion, P
was determined at a wavelength of 213.6 nm with D2 back-
ground correction and with a La chemical modier (1000 mg
mL1 La solution). Optimal pyrolysis and atomisation temper-
atures were 1600 and 2700 C and spiked recovery was 94% 
11% (n ¼ 3) with an LOD of 0.15 mg g1 dw.
7.2.7 Meat and poultry. The content of SeMet, SeCys and
total Se in turkey meat was assessed using HPLC-ICP-MS by
Juniper et al.154 aer dietary supplementation for 84 days
with selenized yeast (SY) or sodium selenite at two levels
(low: 0.3 mg kg1 and high 0.45 mg kg1; control 0.2 mg kg1).
There were signicant differences between both types and levels
of supplementation, although accumulation was highest in
birds fed SY. Visceral tissues contained predominantly SeCys
whereas breast meat comprised mainly SeMet. Thigh meat also
contained more SeCys than SeMet. Alligator (A. mississippiensis)
meat and bone were analysed by ICP-AES.155 Concentrations of
Cd and Pb were below the LOD of 0.5 mg g1 and the measured
concentrations of Cu, Fe and Zn were not considered potentially
toxic. A simple method for sample preparation using TMAHwas
proposed for the determination of Ca, Fe and Mg in fresh and
processed meat using FAAS and ETAAS for Cu.156 No spectral
interferences were found for Cu determination following
investigations with HR-CS-AAS.
7.2.8 Drinking water and non-alcoholic beverages. Safe
levels of B in drinking water are still open for question and work
by Cortes et al.113 highlighted issues in northern Chile, an area
naturally high in this element. This study represented the rst
detailed assessment of B exposure in Chilean tap and bottled
water (173 samples) analysed by ICP-AES, along with urine
provided by volunteers (22 samples) over four years. Boron
concentrations in bottled water samples ranged from 0.01 to
12.2 mg L1 while themedian value for tap water was 2.9 mg L1
(range 0.22–11.3 mg L1). Urinary B concentrations (0.45–17.4
mg L1, median 4.28 mg L1) were shown to be correlated with
the volunteers' tap water consumption of B (r ¼ 0.64). An
indirect XRF determination of Li in mineral water, mediated by
Fe precipitation with KLiFeIO6 complex, was discussed by
Zawisza and Sitko.72 The solution containing the complex was
















































View Article Onlinedetermined. Mineral water samples collected from therapeutic
sources contained between 3.3 and 12.5 ppm which the authors
situate higher than tap water but much less thanmedical doses.
Amethod for the speciation of Cr andMn by FAAS was proposed
using a Ni–Al layered double hydroxide as SPE nano-sorbent.80
At pH 6, adsorption of CrVI and MnVII oxyanions onto the
sorbent occurred with the lower valence ions passing through
unretained. Total concentrations were determined aer oxida-
tion with H2O2 and KIO4. Aer optimisation, the Cr
VI and MnVII
LODs were measured as 0.51 and 0.47 ng mL1, respectively.
Mandiwana et al.157 used ETAAS to analyse different teas and
showed that up to 20% of total Cr was present as CrVI in black
compared to 14% in green tea with none detected in herbal tea.
Total concentrations were measured following acid digestion
while Na2CO3 was used to extract Cr
VI. Average total Cr concen-
trationswere 0.70 0.29mg g1 in green tea, 0.95 0.27mg g1 in
herbal tea with black tea having the highest average concentra-
tion of 4.38 4.23mg g1. Themaximumconcentration of CrVI in
black tea was 3.15 mg g1. Determination of F in teas was carried
out by Mores et al.61 using the 606.44 nm molecular absorption
band of CaF in the graphite atomiser of an HR-CS-AAS spec-
trometer. An LODof 1.6 ngwas obtainedwith a linear range up to
25 mg L1. Total F for 10 samples was determined between 42
and 87 mg g1 with extraction rates from 48% to 74%.
7.2.9 Alcoholic beverages. Mercury speciation (iHg, MeHg)
in red wine was carried out using GC-ICP-MS with NaBPh4 deri-
vatisation (1%m/v) and FI-CV-ICP-MS for total Hg.65 The authors
reported only total Hg concentrations in samples from South
America as other species were below their respective LODs. Total
Hg reached amaximumof 0.55 0.02 mg L1. The determination
of the lanthanide series elements in wine is oen undertaken out
for authenticity purposes, although it is problematic. Bentlin
et al.45 indicated that the use of an ultrasonic probe for 90 s with a
10-fold dilution gave best results in sample preparation for
determination by ICP-MS. Lanthanide concentration data
allowed discrimination of red wines from three countries from
South America. An impressive set of analytical data from nearly
1400 Australian wine samples and 56 elements determined by
ICP-MS and ICP-AES was published by Martin et al.158 Wine
growing regions from within the same state were easily discrim-
inated with LDA with the exception of South Australia where
several geographical indications are situated in close proximity.Abbreviations2DJ. Anal. At. SpTwo-dimensional
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PIGE Particle-induced gamma ray emission
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RM Reference material
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SPE Solid phase extraction
SRM Standard reference material
SR-XRF Synchrotron radiation X-ray uorescence
TEM Transmission electron microscopy
TMAH Tetramethylammonium hydroxide
TOF Time-of-ight
TXRF Total reection X-ray uorescence
UPLC Ultra performance liquid chromatography
UV Ultraviolet
WHO World Health Organisation
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